| Year |
Citation |
Score |
| 2024 |
Tao CY, Wu XL, Song SS, Tang Z, Zhou YF, Tian MX, Jiang XF, Fang Y, Zhu GQ, Huang R, Qu WF, Gao J, Chu TH, Yang R, Chen JF, ... ... Fan J, et al. Downregulation of GPX8 in hepatocellular carcinoma: impact on tumor stemness and migration. Cellular Oncology (Dordrecht). PMID 38607517 DOI: 10.1007/s13402-024-00934-w |
0.401 |
|
| 2024 |
Li ZC, Wang J, Liu HB, Zheng YM, Huang JH, Cai JB, Zhang L, Liu X, Du L, Yang XT, Chai XQ, Jiang YH, Ren ZG, Zhou J, Fan J, et al. Proteomic and metabolomic features in patients with HCC responding to lenvatinib and anti-PD1 therapy. Cell Reports. 43: 113877. PMID 38421869 DOI: 10.1016/j.celrep.2024.113877 |
0.336 |
|
| 2024 |
Xie P, Yu M, Zhang B, Yu Q, Zhao Y, Wu M, Jin L, Yan J, Zhou B, Liu S, Li X, Zhou C, Zhu X, Huang C, Xu Y, ... ... Fan J, et al. CRKL dictates anti-PD-1 resistance by mediating tumor-associated neutrophil infiltration in hepatocellular carcinoma. Journal of Hepatology. PMID 38403027 DOI: 10.1016/j.jhep.2024.02.009 |
0.345 |
|
| 2024 |
Hong W, Zhang Y, Wang S, Li Z, Zheng D, Hsu S, Zhou J, Fan J, Chen Z, Xia X, Zeng Z, Gao Q, Yu M, Du S. RECQL4 Inhibits Radiation-Induced Tumor Immune Awakening via Suppressing the cGAS-STING Pathway in Hepatocellular Carcinoma. Advanced Science (Weinheim, Baden-Wurttemberg, Germany). e2308009. PMID 38381090 DOI: 10.1002/advs.202308009 |
0.426 |
|
| 2024 |
Yang X, Yang C, Zhang S, Geng H, Zhu AX, Bernards R, Qin W, Fan J, Wang C, Gao Q. Precision treatment in advanced hepatocellular carcinoma. Cancer Cell. 42: 180-197. PMID 38350421 DOI: 10.1016/j.ccell.2024.01.007 |
0.354 |
|
| 2024 |
Li RS, Li LY, Zhu XF, Li X, Wang CY, Qiu SJ, Zhou J, Fan J, Hu B, Mu Q. Annonaceous Acetogenins Synergistically Inhibit Hepatocellular Carcinoma with Sorafenib. Journal of Natural Products. PMID 38233978 DOI: 10.1021/acs.jnatprod.3c00667 |
0.389 |
|
| 2023 |
Hong W, Zhang Y, Wang S, Zheng D, Hsu S, Zhou J, Fan J, Zeng Z, Wang N, Ding Z, Yu M, Gao Q, Du S. Deciphering the immune modulation through deep transcriptomic profiling and therapeutic implications of DNA damage repair pattern in hepatocellular carcinoma. Cancer Letters. 216594. PMID 38135208 DOI: 10.1016/j.canlet.2023.216594 |
0.348 |
|
| 2023 |
Sun Y, Wu P, Zhang Z, Wang Z, Zhou K, Song M, Ji Y, Zang F, Lou L, Rao K, Wang P, Gu Y, Gu J, Lu B, Chen L, ... ... Fan J, et al. Integrated multi-omics profiling to dissect the spatiotemporal evolution of metastatic hepatocellular carcinoma. Cancer Cell. PMID 38101410 DOI: 10.1016/j.ccell.2023.11.010 |
0.383 |
|
| 2023 |
Zhou PY, Zhou C, Gan W, Tang Z, Sun BY, Huang JL, Liu G, Liu WR, Tian MX, Jiang XF, Wang H, Tao CY, Fang Y, Qu WF, Huang R, ... ... Fan J, et al. Single-cell and spatial architecture of primary liver cancer. Communications Biology. 6: 1181. PMID 37985711 DOI: 10.1038/s42003-023-05455-0 |
0.375 |
|
| 2023 |
Zhou C, Sun BY, Zhou PY, Yang ZF, Wang ZT, Liu G, Gan W, Wang Z, Zhou J, Fan J, Yi Y, Ren N, Qiu SJ. MAIT cells confer resistance to Lenvatinib plus anti-PD1 antibodies in hepatocellular carcinoma through TNF-TNFRSF1B pathway. Clinical Immunology (Orlando, Fla.). 256: 109770. PMID 37717672 DOI: 10.1016/j.clim.2023.109770 |
0.322 |
|
| 2023 |
Zheng Y, Wang Y, Lu Z, Wan J, Jiang L, Song D, Wei C, Gao C, Shi G, Zhou J, Fan J, Ke A, Zhou L, Cai J. PGAM1 Inhibition Promotes HCC Ferroptosis and Synergizes with Anti-PD-1 Immunotherapy. Advanced Science (Weinheim, Baden-Wurttemberg, Germany). e2301928. PMID 37705495 DOI: 10.1002/advs.202301928 |
0.379 |
|
| 2023 |
Li X, Gao Z, Chen J, Feng S, Luo X, Shi Y, Tang Z, Liu W, Zhang X, Huang A, Gao Q, Ke A, Zhou J, Fan J, Fu X, et al. Integrated single cell and bulk sequencing analysis identifies tumor reactive CXCR6 CD8 T cells as a predictor of immune infiltration and immunotherapy outcomes in hepatocellular carcinoma. Frontiers in Oncology. 13: 1099385. PMID 37593098 DOI: 10.3389/fonc.2023.1099385 |
0.311 |
|
| 2023 |
Zhu H, Lin Y, Lu D, Wang S, Liu Y, Dong L, Meng Q, Gao J, Wang Y, Song N, Suo Y, Ding L, Wang P, Zhang B, Gao D, ... Fan J, et al. Proteomics of adjacent-to-tumor samples uncovers clinically relevant biological events in hepatocellular carcinoma. National Science Review. 10: nwad167. PMID 37575948 DOI: 10.1093/nsr/nwad167 |
0.399 |
|
| 2023 |
Han WY, Wang J, Zhao J, Zheng YM, Chai XQ, Gao C, Cai JB, Ke AW, Fan J, Gao PT, Sun HX. WDR4/TRIM28 is a novel molecular target linked to lenvatinib resistance that helps retain the stem characteristics in hepatocellular carcinomas. Cancer Letters. 216259. PMID 37279851 DOI: 10.1016/j.canlet.2023.216259 |
0.38 |
|
| 2023 |
Huang C, Zhu XD, Shen YH, Xu B, Wu D, Ji Y, Chen LL, Song TQ, Zhang W, Zeng ZM, Huang HS, Wang K, Huang LQ, Chen YJ, Yang YC, ... ... Fan J, et al. Radiographic and α-fetoprotein response predict pathologic complete response to immunotherapy plus a TKI in hepatocellular carcinoma: a multicenter study. Bmc Cancer. 23: 416. PMID 37158833 DOI: 10.1186/s12885-023-10898-z |
0.358 |
|
| 2023 |
Zhang SY, Guo DZ, Zhang X, Fan J, Zhou J, Huang A. Prognosis of spontaneously ruptured hepatocellular carcinoma: a propensity score matching study. Journal of Cancer Research and Clinical Oncology. PMID 37154926 DOI: 10.1007/s00432-023-04774-3 |
0.412 |
|
| 2023 |
Xie DY, Zhu K, Ren ZG, Zhou J, Fan J, Gao Q. A review of 2022 Chinese clinical guidelines on the management of hepatocellular carcinoma: updates and insights. Hepatobiliary Surgery and Nutrition. 12: 216-228. PMID 37124695 DOI: 10.21037/hbsn-22-469 |
0.396 |
|
| 2023 |
Dong ZR, Cai JB, Shi GM, Yang YF, Huang XY, Zhang C, Dong RZ, Wei CY, Li T, Ke AW, Fan J. Oncogenic miR-93-5p/Gal-9 axis drives CD8 (+) T-cell inactivation and is a therapeutic target for hepatocellular carcinoma immunotherapy. Cancer Letters. 564: 216186. PMID 37105392 DOI: 10.1016/j.canlet.2023.216186 |
0.315 |
|
| 2023 |
Qu WF, Tian MX, Lu HW, Zhou YF, Liu WR, Tang Z, Yao Z, Huang R, Zhu GQ, Jiang XF, Tao CY, Fang Y, Gao J, Wu XL, Chen JF, ... ... Fan J, et al. Development of a deep pathomics score for predicting hepatocellular carcinoma recurrence after liver transplantation. Hepatology International. PMID 37031334 DOI: 10.1007/s12072-023-10511-2 |
0.344 |
|
| 2023 |
Gao Z, Feng SR, Chen JF, Li XG, Shi YH, Tang Z, Liu WR, Zhang X, Huang A, Luo XM, Zeng HY, Gao Q, Shi GM, Ke AW, Zhou J, ... Fan J, et al. Inhibition of autophagy in macrophage promotes IL-1β-mediated hepatocellular carcinoma progression via inflammasome accumulation and self-recruitment. Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie. 161: 114560. PMID 36940618 DOI: 10.1016/j.biopha.2023.114560 |
0.369 |
|
| 2023 |
Guo DZ, Zhang SY, Dong SY, Yan JY, Wang YP, Cao Y, Rao SX, Fan J, Yang XR, Huang A, Zhou J. Circulating immune index predicting the prognosis of patients with hepatocellular carcinoma treated with lenvatinib and immunotherapy. Frontiers in Oncology. 13: 1109742. PMID 36910622 DOI: 10.3389/fonc.2023.1109742 |
0.366 |
|
| 2023 |
Zhu GQ, Tang Z, Huang R, Qu WF, Fang Y, Yang R, Tao CY, Gao J, Wu XL, Sun HX, Zhou YF, Song SS, Ding ZB, Dai Z, Zhou J, ... ... Fan J, et al. CD36 cancer-associated fibroblasts provide immunosuppressive microenvironment for hepatocellular carcinoma via secretion of macrophage migration inhibitory factor. Cell Discovery. 9: 25. PMID 36878933 DOI: 10.1038/s41421-023-00529-z |
0.355 |
|
| 2023 |
Guo XJ, Huang XY, Yang X, Lu JC, Wei CY, Gao C, Pei YZ, Chen Y, Sun QM, Cai JB, Zhou J, Fan J, Ke AW, Shi YG, Shen YH, et al. Loss of 5-hydroxymethylcytosine induces chemotherapy resistance in hepatocellular carcinoma via the 5-hmC/PCAF/AKT axis. Cell Death & Disease. 14: 79. PMID 36732324 DOI: 10.1038/s41419-022-05406-3 |
0.368 |
|
| 2023 |
Jiang X, Deng W, Tao S, Tang Z, Chen Y, Tian M, Wang T, Tao C, Li Y, Fang Y, Pu C, Gao J, Wang X, Qu W, Gai X, ... ... Fan J, et al. A RIPK3-independent role of MLKL in suppressing parthanatos promotes immune evasion in hepatocellular carcinoma. Cell Discovery. 9: 7. PMID 36650126 DOI: 10.1038/s41421-022-00504-0 |
0.37 |
|
| 2023 |
Yang Z, Yan C, Ma J, Peng P, Ren X, Cai S, Shen X, Wu Y, Zhang S, Wang X, Qiu S, Zhou J, Fan J, Huang H, Gao Q. Lactylome analysis suggests lactylation-dependent mechanisms of metabolic adaptation in hepatocellular carcinoma. Nature Metabolism. PMID 36593272 DOI: 10.1038/s42255-022-00710-w |
0.34 |
|
| 2022 |
Xu B, Dong SY, Bai XL, Song TQ, Zhang BH, Zhou LD, Chen YJ, Zeng ZM, Wang K, Zhao HT, Lu N, Zhang W, Li XB, Zheng SS, Long G, ... ... Fan J, et al. Tumor Radiomic Features on Pretreatment MRI to Predict Response to Lenvatinib plus an Anti-PD-1 Antibody in Advanced Hepatocellular Carcinoma: A Multicenter Study. Liver Cancer. 12: 262-276. PMID 37601982 DOI: 10.1159/000528034 |
0.353 |
|
| 2022 |
Shen YH, Huang C, Zhu XD, Xu MH, Chen ZS, Tan CJ, Zhou J, Fan J, Sun HC. The Safety Profile of Hepatectomy Following Preoperative Systemic Therapy with Lenvatinib Plus Anti-PD-1 Antibodies Versus Hepatectomy Alone in Patients With Hepatocellular Carcinoma. Annals of Surgery Open : Perspectives of Surgical History, Education, and Clinical Approaches. 3: e163. PMID 37601608 DOI: 10.1097/AS9.0000000000000163 |
0.313 |
|
| 2022 |
Ren Z, Shao G, Shen J, Zhang L, Zhu X, Fang W, Sun G, Bai Y, Wu J, Liu L, Yuan Y, Zhang J, Li Z, Zhang L, Yin T, ... ... Fan J, et al. Phase 2 Study of the PD-1 Inhibitor Serplulimab plus the Bevacizumab Biosimilar HLX04 in Patients with Previously Treated Advanced Hepatocellular Carcinoma. Liver Cancer. 12: 116-128. PMID 37325495 DOI: 10.1159/000526638 |
0.329 |
|
| 2022 |
Yang Y, Sun J, Wu M, Lau WY, Zheng S, Wang XH, Chen X, Fan J, Dong J, Cai J, Chen M, Chen Y, Cheng Z, Dai C, Shan J, et al. Chinese Expert Consensus on Immunotherapy for Hepatocellular Carcinoma (2021 Edition). Liver Cancer. 11: 511-526. PMID 36589726 DOI: 10.1159/000526038 |
0.407 |
|
| 2022 |
Xie D, Shi J, Zhou J, Fan J, Gao Q. Clinical practice guideline and real-life practice in hepatocellular carcinoma: Chinese perspective. Clinical and Molecular Hepatology. PMID 36545708 DOI: 10.3350/cmh.2022.0402 |
0.34 |
|
| 2022 |
Yi Y, Sun BY, Weng JL, Zhou C, Zhou CH, Cai MH, Zhang JY, Gao H, Sun J, Zhou J, Fan J, Ren N, Qiu SJ. Lenvatinib plus anti-PD-1 therapy represents a feasible conversion resection strategy for patients with initially unresectable hepatocellular carcinoma: A retrospective study. Frontiers in Oncology. 12: 1046584. PMID 36505772 DOI: 10.3389/fonc.2022.1046584 |
0.315 |
|
| 2022 |
Xu B, Zhu XD, Shen YH, Zhu JJ, Liu J, Li ML, Tang PW, Zhou J, Fan J, Sun HC, Huang C. Criteria for identifying potentially resectable patients with initially oncologically unresectable hepatocellular carcinoma before treatment with lenvatinib plus an anti-PD-1 antibody. Frontiers in Immunology. 13: 1016736. PMID 36505445 DOI: 10.3389/fimmu.2022.1016736 |
0.347 |
|
| 2022 |
Jin AL, Ding L, Yang WJ, Liu T, Chen W, Li T, Zhang CY, Pan BS, Qiu SJ, Zhou J, Fan J, Guo W, Yang XR, Wang BL. Exosomal microRNAs in the DLK1-DIO3 imprinted region derived from cancer-associated fibroblasts promote progression of hepatocellular carcinoma by targeting hedgehog interacting protein. Bmc Gastroenterology. 22: 505. PMID 36482325 DOI: 10.1186/s12876-022-02594-2 |
0.406 |
|
| 2022 |
Guo DZ, Cheng JW, Yan JY, Huang A, Wang YP, Zhang SY, Cao Y, Huang XW, Fan J, Zhou J, Yang XR. Efficacy and safety of lenvatinib for preventing tumor recurrence after liver transplantation in hepatocellular carcinoma beyond the Milan criteria. Annals of Translational Medicine. 10: 1091. PMID 36388794 DOI: 10.21037/atm-22-1353 |
0.403 |
|
| 2022 |
Huang JH, Wang J, Chai XQ, Li ZC, Jiang YH, Li J, Liu X, Fan J, Cai JB, Liu F. The Intratumoral Bacterial Metataxonomic Signature of Hepatocellular Carcinoma. Microbiology Spectrum. e0098322. PMID 36173308 DOI: 10.1128/spectrum.00983-22 |
0.412 |
|
| 2022 |
Yang W, Wang B, Yu Q, Liu T, Li T, Tian T, Jin A, Ding L, Chen W, Wang H, Xian J, Pan B, Zhou J, Fan J, Yang X, et al. ARHGAP24 represses β-catenin transactivation-induced invasiveness in hepatocellular carcinoma mainly by acting as a GTPase-independent scaffold. Theranostics. 12: 6189-6206. PMID 36168627 DOI: 10.7150/thno.72134 |
0.462 |
|
| 2022 |
Qu WF, Ding ZB, Qu XD, Tang Z, Zhu GQ, Fu XT, Zhang ZH, Zhang X, Huang A, Tang M, Tian MX, Jiang XF, Huang R, Tao CY, Fang Y, ... ... Fan J, et al. Conversion therapy for initially unresectable hepatocellular carcinoma using a combination of toripalimab, lenvatinib plus TACE: real-world study. Bjs Open. 6. PMID 36125345 DOI: 10.1093/bjsopen/zrac114 |
0.31 |
|
| 2022 |
Li Z, Zhang Y, Hong W, Wang B, Chen Y, Yang P, Zhou J, Fan J, Zeng Z, Du S. Gut microbiota modulate radiotherapy-associated antitumor immune responses against hepatocellular carcinoma Via STING signaling. Gut Microbes. 14: 2119055. PMID 36093568 DOI: 10.1080/19490976.2022.2119055 |
0.359 |
|
| 2022 |
Song DJ, Zhu K, Tan JP, Cai JB, Lv MZ, Hu J, Ding ZB, Shi GM, Ren N, Huang XW, Shi YH, Qiu SJ, Ye QH, Sun HC, Gao Q, ... ... Fan J, et al. Perioperative and oncologic outcomes of laparoscopic versus open liver resection for combined hepatocellular-cholangiocarcinoma: a propensity score matching analysis. Surgical Endoscopy. PMID 36076103 DOI: 10.1007/s00464-022-09579-y |
0.363 |
|
| 2022 |
Qu WF, Tian MX, Qiu JT, Guo YC, Tao CY, Liu WR, Tang Z, Qian K, Wang ZX, Li XY, Hu WA, Zhou J, Fan J, Zou H, Hou YY, et al. Exploring pathological signatures for predicting the recurrence of early-stage hepatocellular carcinoma based on deep learning. Frontiers in Oncology. 12: 968202. PMID 36059627 DOI: 10.3389/fonc.2022.968202 |
0.358 |
|
| 2022 |
Pan J, Zhang M, Dong L, Ji S, Zhang J, Zhang S, Lin Y, Wang X, Ding Z, Qiu S, Gao D, Zhou J, Fan J, Gao Q. Genome-Scale CRISPR Screen Identifies LAPTM5 driving lenvatinib resistance in hepatocellular carcinoma. Autophagy. PMID 36037300 DOI: 10.1080/15548627.2022.2117893 |
0.399 |
|
| 2022 |
Peng Y, Wang Z, Qu X, Chen F, Sun H, Wang X, Ding Z, Tang M, Yu L, Yang X, Gao Q, Tang Z, Lau WY, Fan J, Zhou J. Transcatheter arterial embolization-salvaged ALPPS, a novel ALPPS procedure especially for patients with hepatocellular carcinoma and severe fibrosis/cirrhosis. Hepatobiliary Surgery and Nutrition. 11: 504-514. PMID 36016751 DOI: 10.21037/hbsn-21-466 |
0.389 |
|
| 2022 |
Sun J, Guo R, Bi X, Wu M, Tang Z, Lau WY, Zheng S, Wang X, Yu J, Chen X, Fan J, Dong J, Chen Y, Cui Y, Dai C, et al. Guidelines for Diagnosis and Treatment of Hepatocellular Carcinoma with Portal Vein Tumor Thrombus in China (2021 Edition). Liver Cancer. 11: 315-328. PMID 35978596 DOI: 10.1159/000523997 |
0.38 |
|
| 2022 |
Sun Y, Zhang W, Bi X, Yang Z, Tang Y, Jiang L, Bi F, Chen M, Cheng S, Chi Y, Han Y, Huang J, Huang Z, Ji Y, Jia L, ... ... Fan J, et al. Systemic Therapy for Hepatocellular Carcinoma: Chinese Consensus-Based Interdisciplinary Expert Statements. Liver Cancer. 11: 192-208. PMID 35949289 DOI: 10.1159/000521596 |
0.354 |
|
| 2022 |
Huang R, Zhu G, Fu X, Liu W, Tao C, Gao J, Qu W, Fang Y, Jiang X, Ding Z, Zhou J, Shi Y, Fan J, Tang Z. Comprehensive analysis of complement-associated molecular features in hepatocellular carcinoma. Acta Biochimica Et Biophysica Sinica. PMID 35929594 DOI: 10.3724/abbs.2022097 |
0.318 |
|
| 2022 |
Zheng WJ, Wang PX, Sun YF, Cheng JW, Zhong YC, Xu Y, Guo W, Hu B, Zhou J, Fan J, Chen X, Yang XR. Uncovering the Heterogeneity and Clinical Relevance of Circulating Tumor-Initiating Cells in Hepatocellular Carcinoma Using an Integrated Immunomagnetic-Microfluidic Platform. Acs Applied Materials & Interfaces. PMID 35917454 DOI: 10.1021/acsami.2c09085 |
0.408 |
|
| 2022 |
Xu X, Huang A, Guo DZ, Wang YP, Zhang SY, Yan JY, Wang XY, Cao Y, Fan J, Zhou J, Fu XT, Shi YH. Integration of Inflammation-Immune Factors to Build Prognostic Model Predictive of Prognosis and Minimal Residual Disease for Hepatocellular Carcinoma. Frontiers in Oncology. 12: 893268. PMID 35756674 DOI: 10.3389/fonc.2022.893268 |
0.381 |
|
| 2022 |
Xu MH, Xu B, Zhou CH, Xue Z, Chen ZS, Xu WX, Huang C, Zhu XD, Zhou J, Fan J, Sun HC, Shen YH. An mALBI-Child-Pugh-based nomogram for predicting post-hepatectomy liver failure grade B-C in patients with huge hepatocellular carcinoma: a multi-institutional study. World Journal of Surgical Oncology. 20: 206. PMID 35710377 DOI: 10.1186/s12957-022-02672-5 |
0.388 |
|
| 2022 |
Zhou C, Zhang X, Zhou K, Hou Y, Chen F, Zhang X, Ji Y, Qiu S, Fan J, Zhou J, Zhou Y, Wang Z. Long-term outcomes and prognosis for patients with sarcomatoid hepatocellular carcinoma. Annals of Translational Medicine. 10: 394. PMID 35530933 DOI: 10.21037/atm-21-4322 |
0.351 |
|
| 2022 |
Gao C, Wang SW, Lu JC, Chai XQ, Li YC, Zhang PF, Huang XY, Cai JB, Zheng YM, Guo XJ, Shi GM, Ke AW, Fan J. KSR2-14-3-3ζ complex serves as a biomarker and potential therapeutic target in sorafenib-resistant hepatocellular carcinoma. Biomarker Research. 10: 25. PMID 35468812 DOI: 10.1186/s40364-022-00361-9 |
0.393 |
|
| 2022 |
Sun HC, Zhou J, Wang Z, Liu X, Xie Q, Jia W, Zhao M, Bi X, Li G, Bai X, Ji Y, Xu L, Zhu XD, Bai D, Chen Y, ... ... Fan J, et al. Chinese expert consensus on conversion therapy for hepatocellular carcinoma (2021 edition). Hepatobiliary Surgery and Nutrition. 11: 227-252. PMID 35464283 DOI: 10.21037/hbsn-21-328 |
0.365 |
|
| 2022 |
Hu B, Yu M, Ma X, Sun J, Liu C, Wang C, Wu S, Fu PY, Yang Z, He Y, Zhu Y, Huang C, Yang X, Shi Y, Qiu S, ... ... Fan J, et al. Interferon-a potentiates anti-PD-1 efficacy by remodeling glucose metabolism in the hepatocellular carcinoma microenvironment. Cancer Discovery. PMID 35412588 DOI: 10.1158/2159-8290.CD-21-1022 |
0.311 |
|
| 2022 |
Jin AL, Zhang CY, Zheng WJ, Xian JR, Yang WJ, Liu T, Chen W, Li T, Wang BL, Pan BS, Li Q, Cheng JW, Wang PX, Hu B, Zhou J, ... Fan J, et al. CD155/SRC complex promotes hepatocellular carcinoma progression via inhibiting the p38 MAPK signalling pathway and correlates with poor prognosis. Clinical and Translational Medicine. 12: e794. PMID 35384345 DOI: 10.1002/ctm2.794 |
0.41 |
|
| 2022 |
Wang Z, Zhong Y, Zhang Z, Zhou K, Huang Z, Yu H, Liu L, Liu S, Yang H, Zhou J, Fan J, Wu L, Sun Y. Characteristics and Clinical Significance of T-Cell Receptor Repertoire in Hepatocellular Carcinoma. Frontiers in Immunology. 13: 847263. PMID 35371059 DOI: 10.3389/fimmu.2022.847263 |
0.372 |
|
| 2022 |
Zhang CH, Cheng Y, Zhang S, Fan J, Gao Q. Changing epidemiology of hepatocellular carcinoma in Asia. Liver International : Official Journal of the International Association For the Study of the Liver. PMID 35319165 DOI: 10.1111/liv.15251 |
0.383 |
|
| 2022 |
Wei CY, Zhu MX, Zhang PF, Huang XY, Wan JK, Yao XZ, Hu ZT, Chai XQ, Peng R, Yang X, Gao C, Gao J, Wang SW, Zheng YM, Tang Z, ... ... Fan J, et al. PKCα/ZFP64/CSF1 axis resets the tumor microenvironment and fuels anti-PD1 resistance in hepatocellular carcinoma. Journal of Hepatology. PMID 35219791 DOI: 10.1016/j.jhep.2022.02.019 |
0.374 |
|
| 2022 |
Yu M, Chen Z, Zhou Q, Zhang B, Huang J, Jin L, Zhou B, Liu S, Yan J, Li X, Zhang W, Liu C, Hu B, Fu P, Zhou C, ... ... Fan J, et al. PARG inhibition limits HCC progression and potentiates the efficacy of immune checkpoint therapy. Journal of Hepatology. PMID 35157958 DOI: 10.1016/j.jhep.2022.01.026 |
0.393 |
|
| 2022 |
Huang A, Guo DZ, Wang YP, Fan J, Yang XR, Zhou J. The treatment strategy and outcome for spontaneously ruptured hepatocellular carcinoma: a single-center experience in 239 patients. Journal of Cancer Research and Clinical Oncology. PMID 35118561 DOI: 10.1007/s00432-022-03916-3 |
0.35 |
|
| 2022 |
Guan RY, Sun BY, Wang ZT, Zhou C, Yang ZF, Gan W, Huang JL, Liu G, Zhou J, Fan J, Yi Y, Qiu SJ. Antiviral therapy improves postoperative survival of patients with HBV-related hepatocellular carcinoma. American Journal of Surgery. PMID 35115174 DOI: 10.1016/j.amjsurg.2022.01.008 |
0.383 |
|
| 2022 |
Jin AL, Yang YH, Su X, Yang WJ, Liu T, Chen W, Li T, Ding L, Wang H, Wang BL, Pan BS, Zhou J, Fan J, Yang XR, Guo W. High serum soluble CD155 level predicts poor prognosis and correlates with an immunosuppressive tumor microenvironment in hepatocellular carcinoma. Journal of Clinical Laboratory Analysis. e24259. PMID 35089611 DOI: 10.1002/jcla.24259 |
0.454 |
|
| 2022 |
Zhou SL, Zhou ZJ, Song CL, Xin HY, Hu ZQ, Luo CB, Luo YJ, Li J, Dai Z, Yang XR, Shi YH, Wang Z, Huang XW, Fan J, Zhou J. Whole-genome sequencing reveals the evolutionary trajectory of HBV-related hepatocellular carcinoma early recurrence. Signal Transduction and Targeted Therapy. 7: 24. PMID 35078970 DOI: 10.1038/s41392-021-00838-3 |
0.391 |
|
| 2022 |
Li J, Hu ZQ, Yu S, Mao L, Zhou Z, Wang P, Gong Y, Su S, Zhou J, Fan J, Zhou SL, Huang X. CircRPN2 inhibits aerobic glycolysis and metastasis in hepatocellular carcinoma. Cancer Research. PMID 35045986 DOI: 10.1158/0008-5472.CAN-21-1259 |
0.436 |
|
| 2022 |
Fang Y, Liu W, Tang Z, Ji X, Zhou Y, Song S, Tian M, Tao C, Huang R, Zhu G, Jiang X, Gao J, Qu W, Wang H, Zhou P, ... ... Fan J, et al. MCT4 inhibition potentiates hepatocellular carcinoma immunotherapy via enhancing T cell infiltration and immune attack. Hepatology (Baltimore, Md.). PMID 35043976 DOI: 10.1002/hep.32348 |
0.354 |
|
| 2022 |
Du SS, Chen GW, Yang P, Chen YX, Hu Y, Zhao QQ, Zhang Y, Liu R, Zheng DX, Zhou J, Fan J, Zeng ZC. Radiation therapy promotes hepatocellular carcinoma immune-cloaking via PD-L1 upregulation induced by cGAS-STING activation. International Journal of Radiation Oncology, Biology, Physics. PMID 34986380 DOI: 10.1016/j.ijrobp.2021.12.162 |
0.332 |
|
| 2021 |
Guo DZ, Huang A, Wang YP, Cao Y, Fan J, Yang XR, Zhou J. Development of an Eight-gene Prognostic Model for Overall Survival Prediction in Patients with Hepatocellular Carcinoma. Journal of Clinical and Translational Hepatology. 9: 898-908. PMID 34966653 DOI: 10.14218/JCTH.2020.00152 |
0.396 |
|
| 2021 |
Zhang X, Wang Z, Tang W, Wang X, Liu R, Bao H, Chen X, Wei Y, Wu S, Bao H, Wu X, Shao Y, Fan J, Zhou J. Ultra-Sensitive and Affordable Assay for Early Detection of Primary Liver Cancer Using Plasma cfDNA Fragmentomics. Hepatology (Baltimore, Md.). PMID 34954829 DOI: 10.1002/hep.32308 |
0.39 |
|
| 2021 |
Li M, Tang Y, Wang D, Zhai X, Shen H, Zhong C, Yao M, Jin A, Zhou Z, Zhou S, Fan J, Ling CQ, Ling C. Sphingosine-1-phosphate transporter spinster homologue 2 is essential for iron-regulated metastasis of hepatocellular carcinoma. Molecular Therapy : the Journal of the American Society of Gene Therapy. PMID 34547466 DOI: 10.1016/j.ymthe.2021.09.012 |
0.401 |
|
| 2021 |
Zhu GQ, Liu WR, Tang Z, Qu WF, Fang Y, Jiang XF, Song SS, Wang H, Tao CY, Zhou PY, Huang R, Gao J, Sun HX, Ding ZB, Peng YF, ... ... Fan J, et al. Serial circulating tumor DNA to predict early recurrence in patients with hepatocellular carcinoma: a prospective study. Molecular Oncology. PMID 34543520 DOI: 10.1002/1878-0261.13105 |
0.329 |
|
| 2021 |
Fan J. Sintilimab plus IBI305 for hepatocellular carcinoma - Author's reply. The Lancet. Oncology. 22: e388. PMID 34478672 DOI: 10.1016/S1470-2045(21)00479-4 |
0.342 |
|
| 2021 |
Zhu XD, Huang C, Shen YH, Ji Y, Ge NL, Qu XD, Chen L, Shi WK, Li ML, Zhu JJ, Tan CJ, Tang ZY, Zhou J, Fan J, Sun HC. Downstaging and Resection of Initially Unresectable Hepatocellular Carcinoma with Tyrosine Kinase Inhibitor and Anti-PD-1 Antibody Combinations. Liver Cancer. 10: 320-329. PMID 34414120 DOI: 10.1159/000514313 |
0.366 |
|
| 2021 |
Zhou YF, Song SS, Tian MX, Tang Z, Wang H, Fang Y, Qu WF, Jiang XF, Tao CY, Huang R, Zhou PY, Zhu SG, Zhou J, Fan J, Liu WR, et al. Cystathionine β-synthase mediated PRRX2/IL-6/STAT3 inactivation suppresses Tregs infiltration and induces apoptosis to inhibit HCC carcinogenesis. Journal For Immunotherapy of Cancer. 9. PMID 34413167 DOI: 10.1136/jitc-2021-003031 |
0.396 |
|
| 2021 |
Yu MC, Ding GY, Ma P, Chen YD, Zhu XD, Cai JB, Shen YH, Zhou J, Fan J, Sun HC, Kuang M, Huang C. CircRNA UBAP2 serves as a sponge of miR-1294 to increase tumorigenesis in hepatocellular carcinoma through regulating c-Myc expression. Carcinogenesis. PMID 34314478 DOI: 10.1093/carcin/bgab068 |
0.401 |
|
| 2021 |
Yin Y, Cheng JW, Chen FY, Chen XX, Zhang X, Huang A, Guo DZ, Wang YP, Cao Y, Fan J, Zhou J, Yang XR. A novel preoperative predictive model of 90-day mortality after liver resection for huge hepatocellular carcinoma. Annals of Translational Medicine. 9: 774. PMID 34268387 DOI: 10.21037/atm-20-7842 |
0.363 |
|
| 2021 |
Sun YF, Wu L, Liu SP, Jiang MM, Hu B, Zhou KQ, Guo W, Xu Y, Zhong Y, Zhou XR, Zhang ZF, Liu G, Liu S, Shi YH, Ji Y, ... ... Fan J, et al. Dissecting spatial heterogeneity and the immune-evasion mechanism of CTCs by single-cell RNA-seq in hepatocellular carcinoma. Nature Communications. 12: 4091. PMID 34215748 DOI: 10.1038/s41467-021-24386-0 |
0.329 |
|
| 2021 |
Ren Z, Xu J, Bai Y, Xu A, Cang S, Du C, Li Q, Lu Y, Chen Y, Guo Y, Chen Z, Liu B, Jia W, Wu J, Wang J, ... ... Fan J, et al. Sintilimab plus a bevacizumab biosimilar (IBI305) versus sorafenib in unresectable hepatocellular carcinoma (ORIENT-32): a randomised, open-label, phase 2-3 study. The Lancet. Oncology. PMID 34143971 DOI: 10.1016/S1470-2045(21)00252-7 |
0.378 |
|
| 2021 |
Chen X, Huang A, Wang Y, Chen F, Hu B, Zhang X, Sun Y, Wang J, Cheng J, Wang P, Ji Y, Qiu S, Fan J, Zhou J, Yang X. BRCA1-associated protein 1 serves as a tumor suppressor in hepatocellular carcinoma by deubiquitinating and stabilizing PTEN. American Journal of Cancer Research. 11: 2044-2061. PMID 34094668 |
0.407 |
|
| 2021 |
Yin D, Hu ZQ, Luo CB, Wang XY, Xin HY, Sun RQ, Wang PC, Li J, Fan J, Zhou ZJ, Zhou J, Zhou SL. LINC01133 promotes hepatocellular carcinoma progression by sponging miR-199a-5p and activating annexin A2. Clinical and Translational Medicine. 11: e409. PMID 34047479 DOI: 10.1002/ctm2.409 |
0.39 |
|
| 2021 |
Dong ZR, Ke AW, Li T, Cai JB, Yang YF, Zhou W, Shi GM, Fan J. CircMEMO1 modulates the promoter methylation and expression of TCF21 to regulate hepatocellular carcinoma progression and sorafenib treatment sensitivity. Molecular Cancer. 20: 75. PMID 33985545 DOI: 10.1186/s12943-021-01361-3 |
0.401 |
|
| 2021 |
Hu JW, Yin Y, Gao Y, Nie YY, Fu PY, Cai JB, Zhu K, Huang C, Huang XW, Yang XR, Cao Y, Qiu SJ, Fan J, Zhou J. TM2D1 contributes the epithelial-mesenchymal transition of hepatocellular carcinoma via modulating AKT/β-catenin axis. American Journal of Cancer Research. 11: 1557-1571. PMID 33948373 |
0.375 |
|
| 2021 |
Song D, Wang Y, Wang W, Wang Y, Cai J, Zhu K, Lv M, Gao Q, Zhou J, Fan J, Rao S, Wang M, Wang X. Using deep learning to predict microvascular invasion in hepatocellular carcinoma based on dynamic contrast-enhanced MRI combined with clinical parameters. Journal of Cancer Research and Clinical Oncology. PMID 33839938 DOI: 10.1007/s00432-021-03617-3 |
0.339 |
|
| 2021 |
Chai X, Guo J, Dong R, Yang X, Deng C, Wei C, Xu J, Han W, Lu J, Gao C, Gao D, Huang C, Ke A, Li S, Li H, ... ... Fan J, et al. Quantitative acetylome analysis reveals histone modifications that may predict prognosis in hepatitis B-related hepatocellular carcinoma. Clinical and Translational Medicine. 11: e313. PMID 33783990 DOI: 10.1002/ctm2.313 |
0.375 |
|
| 2021 |
Liu G, Sun J, Yang ZF, Zhou C, Zhou PY, Guan RY, Sun BY, Wang ZT, Zhou J, Fan J, Qiu SJ, Yi Y. Cancer-associated fibroblast-derived CXCL11 modulates hepatocellular carcinoma cell migration and tumor metastasis through the circUBAP2/miR-4756/IFIT1/3 axis. Cell Death & Disease. 12: 260. PMID 33707417 DOI: 10.1038/s41419-021-03545-7 |
0.366 |
|
| 2021 |
Lyu L, Yang W, Yao J, Wang H, Zhu J, Jin A, Liu T, Wang B, Zhou J, Fan J, Yang X, Guo W. The diagnostic value of plasma exosomal for hepatocellular carcinoma. Biomarkers in Medicine. PMID 33666515 DOI: 10.2217/bmm-2020-0476 |
0.415 |
|
| 2021 |
Zhang X, Hu B, Sun YF, Huang XW, Cheng JW, Huang A, Zeng HY, Qiu SJ, Cao Y, Fan J, Zhou J, Yang XR. Arsenic trioxide induces differentiation of cancer stem cells in hepatocellular carcinoma through inhibition of LIF/JAK1/STAT3 and NF-kB signaling pathways synergistically. Clinical and Translational Medicine. 11: e335. PMID 33634982 DOI: 10.1002/ctm2.335 |
0.331 |
|
| 2020 |
Zhou J, Sun H, Wang Z, Cong W, Wang J, Zeng M, Zhou W, Bie P, Liu L, Wen T, Han G, Wang M, Liu R, Lu L, Ren Z, ... ... Fan J, et al. Guidelines for the Diagnosis and Treatment of Hepatocellular Carcinoma (2019 Edition). Liver Cancer. 9: 682-720. PMID 33442540 DOI: 10.1159/000509424 |
0.355 |
|
| 2020 |
Hu B, Xu Y, Li YC, Huang JF, Cheng JW, Guo W, Yin Y, Gao Y, Wang PX, Wu SY, Zhou J, Fan J, Yang XR. CD13 promotes hepatocellular carcinogenesis and sorafenib resistance by activating HDAC5-LSD1-NF-κB oncogenic signaling. Clinical and Translational Medicine. 10: e233. PMID 33377659 DOI: 10.1002/ctm2.233 |
0.326 |
|
| 2020 |
Sun Y, Wu L, Zhong Y, Zhou K, Hou Y, Wang Z, Zhang Z, Xie J, Wang C, Chen D, Huang Y, Wei X, Shi Y, Zhao Z, Li Y, ... ... Fan J, et al. Single-cell landscape of the ecosystem in early-relapse hepatocellular carcinoma. Cell. PMID 33357445 DOI: 10.1016/j.cell.2020.11.041 |
0.367 |
|
| 2020 |
Song S, Shi Y, Wu W, Wu H, Chang L, Peng P, Zhang L, Fan J, Gu J, Ruan Y. Reticulon 3-mediated Chk2/p53 activation suppresses hepatocellular carcinogenesis and is blocked by hepatitis B virus. Gut. PMID 33303565 DOI: 10.1136/gutjnl-2020-321386 |
0.369 |
|
| 2020 |
Song G, Shi Y, Zhang M, Goswami S, Afridi S, Meng L, Ma J, Chen Y, Lin Y, Zhang J, Liu Y, Jin Z, Yang S, Rao D, Zhang S, ... ... Fan J, et al. Global immune characterization of HBV/HCV-related hepatocellular carcinoma identifies macrophage and T-cell subsets associated with disease progression. Cell Discovery. 6: 90. PMID 33298893 DOI: 10.1038/s41421-020-00214-5 |
0.356 |
|
| 2020 |
Sun HC, Zhu XD, Zhou J, Gao Q, Shi YH, Ding ZB, Huang C, Qiu SJ, Ren N, Shi GM, Sun J, Ye QH, Huang XW, Yang XR, Fan J. Adjuvant apatinib treatment after resection of hepatocellular carcinoma with portal vein tumor thrombosis: a phase II trial. Annals of Translational Medicine. 8: 1301. PMID 33209881 DOI: 10.21037/atm-20-6181 |
0.412 |
|
| 2020 |
Wang PX, Xu Y, Sun YF, Cheng JW, Zhou KQ, Wu SY, Hu B, Zhang ZF, Guo W, Cao Y, Huang XW, Zhou J, Fan J, Yang XR. Detection of Circulating Tumor Cells Enables Early Recurrence Prediction in Hepatocellular Carcinoma Patients undergoing Liver Transplantation. Liver International : Official Journal of the International Association For the Study of the Liver. PMID 33205544 DOI: 10.1111/liv.14734 |
0.417 |
|
| 2020 |
Zhou KQ, Sun YF, Cheng JW, Du M, Ji Y, Wang PX, Hu B, Guo W, Gao Y, Yin Y, Huang JF, Zhou J, Fan J, Yang XR. Effect of surgical margin on recurrence based on preoperative circulating tumor cell status in hepatocellular carcinoma. Ebiomedicine. 62: 103107. PMID 33181461 DOI: 10.1016/j.ebiom.2020.103107 |
0.438 |
|
| 2020 |
Zhou Q, Cai H, Xu MH, Ye Y, Li XL, Shi GM, Huang C, Zhu XD, Cai JB, Zhou J, Fan J, Ji Y, Sun HC, Shen YH. Do the existing staging systems for primary liver cancer apply to combined hepatocellular carcinoma-intrahepatic cholangiocarcinoma? Hepatobiliary & Pancreatic Diseases International : Hbpd Int. PMID 33160852 DOI: 10.1016/j.hbpd.2020.10.002 |
0.322 |
|
| 2020 |
Li Y, Xu Y, Gao C, Sun Y, Zhou K, Wang P, Cheng J, Guo W, Ya C, Fan J, Yang X. USP1 Maintains the Survival of Liver Circulating Tumor Cells by Deubiquitinating and Stabilizing TBLR1. Frontiers in Oncology. 10: 554809. PMID 33102219 DOI: 10.3389/fonc.2020.554809 |
0.378 |
|
| 2020 |
Yang WJ, Sun YF, Jin AL, Lv LH, Zhu J, Wang BL, Zhou Y, Zhang CY, Wang H, Hu B, Wang PX, Te L, Pan BS, Zhou J, Fan J, et al. BCL11B suppresses tumor progression and stem cell traits in hepatocellular carcinoma by restoring p53 signaling activity. Cell Death & Disease. 11: 895. PMID 33093445 DOI: 10.1038/s41419-020-03115-3 |
0.437 |
|
| 2020 |
Wang B, Zhu J, Ma X, Qiu S, Pan B, Zhou J, Fan J, Yang X, Guo W. Tfr-Tfh index: a new predicator for recurrence of hepatocellular carcinoma patients with HBV infection after curative resection. Clinica Chimica Acta; International Journal of Clinical Chemistry. PMID 33080261 DOI: 10.1016/j.cca.2020.10.017 |
0.4 |
|
| 2020 |
Ma XL, Qu XD, Yang WJ, Wang BL, Shen MN, Zhou Y, Zhang CY, Sun YF, Chen JW, Hu B, Gong ZJ, Zhang X, Pan BS, Zhou J, Fan J, et al. Elevated Soluble Programmed Death-ligand 1 levels indicate immunosuppression and poor prognosis in hepatocellular carcinoma patients undergoing transcatheter arterial chemoembolization. Clinica Chimica Acta; International Journal of Clinical Chemistry. PMID 32979338 DOI: 10.1016/j.cca.2020.09.026 |
0.337 |
|
| 2020 |
Zhu GQ, Yu L, Zhou YJ, Du JX, Dong SS, Wu YM, Shi YH, Zhou J, Fan J, Dai Z. Genetic Alterations and Transcriptional Expression of mA RNA Methylation Regulators Drive a Malignant Phenotype and Have Clinical Prognostic Impact in Hepatocellular Carcinoma. Frontiers in Oncology. 10: 900. PMID 32850303 DOI: 10.3389/Fonc.2020.00900 |
0.381 |
|
| 2020 |
Xie DY, Ren ZG, Zhou J, Fan J, Gao Q. 2019 Chinese clinical guidelines for the management of hepatocellular carcinoma: updates and insights. Hepatobiliary Surgery and Nutrition. 9: 452-463. PMID 32832496 DOI: 10.21037/Hbsn-20-480 |
0.375 |
|
| 2020 |
Fu XT, Tang Z, Chen JF, Shi YH, Liu WR, Gao Q, Ding GY, Song K, Wang XY, Zhou J, Fan J, Ding ZB. Laparoscopic hepatectomy enhances recovery for small hepatocellular carcinoma with liver cirrhosis by postoperative inflammatory response attenuation: a propensity score matching analysis with a conventional open approach. Surgical Endoscopy. PMID 32748270 DOI: 10.1007/S00464-020-07710-5 |
0.386 |
|
| 2020 |
Wang PX, Sun YF, Zhou KQ, Cheng JW, Hu B, Guo W, Yin Y, Huang JF, Zhou J, Fan J, Cheung TT, Qu XD, Yang XR. Circulating tumor cells are an indicator for the administration of adjuvant transarterial chemoembolization in hepatocellular carcinoma: A single-center, retrospective, propensity-matched study. Clinical and Translational Medicine. e137. PMID 32702202 DOI: 10.1002/Ctm2.137 |
0.426 |
|
| 2020 |
Song D, Wang Y, Zhu K, Tian L, Gao Q, Zhou J, Fan J, Wang X. DCK is a promising prognostic biomarker and correlated with immune infiltrates in hepatocellular carcinoma. World Journal of Surgical Oncology. 18: 176. PMID 32690026 DOI: 10.1186/S12957-020-01953-1 |
0.383 |
|
| 2020 |
Liu WR, Tian MX, Tao CY, Tang Z, Zhou YF, Song SS, Jiang XF, Wang H, Zhou PY, Qu WF, Fang Y, Ding ZB, Zhou J, Fan J, Shi YH. Adjuvant Transarterial chemoembolization does not influence recurrence-free or overall survival in patients with combined hepatocellular carcinoma and Cholangiocarcinoma after curative resection: a propensity score matching analysis. Bmc Cancer. 20: 642. PMID 32650743 DOI: 10.1186/S12885-020-07138-Z |
0.34 |
|
| 2020 |
Zhang S, Liu Y, Chen J, Shu H, Shen S, Li Y, Lu X, Cao X, Dong L, Shi J, Cao Y, Wang X, Zhou J, Liu Y, Chen L, ... Fan J, et al. Autoantibody signature in hepatocellular carcinoma using seromics. Journal of Hematology & Oncology. 13: 85. PMID 32616055 DOI: 10.1186/S13045-020-00918-X |
0.39 |
|
| 2020 |
Zheng BH, Ma JQ, Tian LY, Dong LQ, Song GH, Pan JM, Liu YM, Yang SX, Wang XY, Zhang XM, Zhou J, Fan J, Shi JY, Gao Q. The distribution of immune cells within combined hepatocellular carcinoma and cholangiocarcinoma predicts clinical outcome. Clinical and Translational Medicine. 10: 45-56. PMID 32508015 DOI: 10.1002/Ctm2.11 |
0.328 |
|
| 2020 |
Sun YF, Wang PX, Cheng JW, Gong ZJ, Huang A, Zhou KQ, Hu B, Gao PT, Cao Y, Qiu SJ, Zhou J, Fan J, Guo W, Yang XR. Postoperative circulating tumor cells: An early predictor of extrahepatic metastases in patients with hepatocellular carcinoma undergoing curative surgical resection. Cancer Cytopathology. PMID 32501632 DOI: 10.1002/Cncy.22304 |
0.375 |
|
| 2020 |
Huang XY, Zhang PF, Wei CY, Peng R, Lu JC, Gao C, Cai JB, Yang X, Fan J, Ke AW, Zhou J, Shi GM. Circular RNA circMET drives immunosuppression and anti-PD1 therapy resistance in hepatocellular carcinoma via the miR-30-5p/snail/DPP4 axis. Molecular Cancer. 19: 92. PMID 32430013 DOI: 10.1186/S12943-020-01213-6 |
0.341 |
|
| 2020 |
Liu WR, Tian MX, Tang Z, Fang Y, Zhou YF, Song SS, Jiang XF, Wang H, Tao CY, Zhou PY, Qu WF, Ding ZB, Peng YF, Zhou J, Fan J, et al. Nine-factor-based immunohistochemistry classifier predicts recurrence for early-stage hepatocellular carcinoma after curative resection. British Journal of Cancer. PMID 32376890 DOI: 10.1038/s41416-020-0864-0 |
0.389 |
|
| 2020 |
Ding GY, Zhu XD, Ji Y, Shi GM, Shen YH, Zhou J, Fan J, Sun HC, Huang C. Serum PON1 as a biomarker for the estimation of microvascular invasion in hepatocellular carcinoma. Annals of Translational Medicine. 8: 204. PMID 32309351 DOI: 10.21037/Atm.2020.01.44 |
0.372 |
|
| 2020 |
Huang A, Wang YP, Wang J, Fu PY, Zhang X, Cao Y, Fan J, Yang XR, Zhou J. Limited bias effect of intratumoral heterogeneity on genetic profiling of hepatocellular carcinoma. Journal of Gastrointestinal Oncology. 11: 112-120. PMID 32175113 DOI: 10.21037/Jgo.2019.09.13 |
0.376 |
|
| 2020 |
Huang JL, Fu YP, Gan W, Liu G, Zhou PY, Zhou C, Sun BY, Guan RY, Zhou J, Fan J, Yi Y, Qiu SJ. Hepatic stellate cells promote the progression of hepatocellular carcinoma through microRNA-1246-RORα-Wnt/β-Catenin axis. Cancer Letters. PMID 32061951 DOI: 10.1016/j.canlet.2020.02.012 |
0.344 |
|
| 2020 |
Liu Y, Lu LL, Wen D, Liu DL, Dong LL, Gao DM, Bian XY, Zhou J, Fan J, Wu WZ. MiR-612 regulates invadopodia of hepatocellular carcinoma by HADHA-mediated lipid reprogramming. Journal of Hematology & Oncology. 13: 12. PMID 32033570 DOI: 10.1186/S13045-019-0841-3 |
0.36 |
|
| 2020 |
Sun H, Zhu X, Zhou J, Gao Q, Shi Y, Ding Z, Huang C, Qiu S, Ren N, Shi G, Sun J, Ye Q, Huang X, Yang X, Fan J. Effect of postoperative apatinib treatment after resection of hepatocellular carcinoma with portal vein invasion: A phase II study. Journal of Clinical Oncology. 38: 514-514. DOI: 10.1200/Jco.2020.38.4_Suppl.514 |
0.344 |
|
| 2020 |
Sun H, Zhu X, Huang C, Shen Y, Ji Y, Ge N, Tan C, Zhou J, Fan J. Initially unresectable hepatocellular carcinoma treated by combination therapy of tyrosine kinase inhibitor and anti-PD-1 antibody followed by resection. Journal of Clinical Oncology. 38: e16690-e16690. DOI: 10.1200/Jco.2020.38.15_Suppl.E16690 |
0.318 |
|
| 2020 |
Dai Q, Zhu J, Shen M, Jiang H, Pan B, Zhou J, Fan J, Yang X, Guo W. C5aR correlated with the dissemination capacity of circulating tumor cells in hepatocellular carcinoma by targeting INHBA-p-smad2/3-EMT/MMPs axis. Journal of Clinical Oncology. 38: e16649-e16649. DOI: 10.1200/Jco.2020.38.15_Suppl.E16649 |
0.411 |
|
| 2020 |
Yang X, Huang A, Wang Y, Peng J, Jiang R, Li Z, Jie Y, Fan J, Zhou J. Genome-wide plasma cell-free DNA methylation profiling to identify high-performing biomarkers for early detection of hepatocellular carcinoma. Journal of Clinical Oncology. 38: 4600-4600. DOI: 10.1200/Jco.2020.38.15_Suppl.4600 |
0.392 |
|
| 2020 |
Jiao SC, Bai L, Dong J, Bai C, Hu C, Shen L, Qin Q, Bai Y, Fan J, Zang A, Han C, Zhu Y, Li J, Zhang P, Ye S, et al. Clinical activity and safety of penpulimab (Anti-PD-1) with anlotinib as first-line therapy for advanced hepatocellular carcinoma (HCC). Journal of Clinical Oncology. 38: 4592-4592. DOI: 10.1200/jco.2020.38.15_suppl.4592 |
0.303 |
|
| 2020 |
Pan X, Lin P, Feng F, Li J, Li Y, Dai W, Hu B, Yang X, Fan J, Li H, Li Y. Comparison of immune profiles between hepatocellular carcinoma subtypes Biophysics Reports. 6: 19-32. DOI: 10.1007/s41048-019-00102-w |
0.331 |
|
| 2019 |
Dong LQ, Peng LH, Ma LJ, Liu DB, Zhang S, Luo SZ, Rao JH, Zhu HW, Yang SX, Xi SJ, Chen M, Xie FF, Li FQ, Li WH, Ye C, ... ... Fan J, et al. Heterogeneous immunogenomic features and distinct escape mechanisms in multifocal hepatocellular carcinoma. Journal of Hepatology. PMID 31887370 DOI: 10.1016/J.Jhep.2019.12.014 |
0.409 |
|
| 2019 |
Cai J, Zhang Z, He C, Zhang W, Fan J. Reply to 'Are the 5-hydroxymethylcytosine-based wd-scores really superior over α-fetoprotein for the early diagnosis of hepatocellular carcinoma?' Gut. PMID 31871104 DOI: 10.1136/Gutjnl-2019-320298 |
0.382 |
|
| 2019 |
Wang W, Hu B, Qin JJ, Cheng JW, Li X, Rajaei M, Fan J, Yang XR, Zhang R. A novel inhibitor of MDM2 oncogene blocks metastasis of hepatocellular carcinoma and overcomes chemoresistance. Genes & Diseases. 6: 419-430. PMID 31832522 DOI: 10.1016/j.gendis.2019.06.001 |
0.381 |
|
| 2019 |
Zhou PY, Yang CP, Tang Z, Yi Y, Liu WR, Tian MX, Huang JL, Gan W, Jiang XF, Liu G, Wang H, Tao CY, Fang Y, Qu WF, Zhou C, ... ... Fan J, et al. Daily decrease of post-operative alpha-fetoprotein by 9% discriminates prognosis of HCC: A multicenter retrospective study. Aging. 11. PMID 31829979 DOI: 10.18632/aging.102513 |
0.365 |
|
| 2019 |
Hu JW, Yang ZF, Li J, Hu B, Luo CB, Zhu K, Dai Z, Cai JB, Zhan H, Hu ZQ, Hu J, Cao Y, Qiu SJ, Zhou J, Fan J, et al. TGM3 promotes epithelial-mesenchymal transition and hepatocellular carcinogenesis and predicts poor prognosis for patients after curative resection. Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association For the Study of the Liver. PMID 31822388 DOI: 10.1016/J.Dld.2019.10.010 |
0.419 |
|
| 2019 |
Gao Q, Zhu H, Dong L, Shi W, Chen R, Song Z, Huang C, Li J, Dong X, Zhou Y, Liu Q, Ma L, Wang X, Zhou J, Liu Y, ... ... Fan J, et al. Integrated Proteogenomic Characterization of HBV-Related Hepatocellular Carcinoma. Cell. 179: 1240. PMID 31730861 DOI: 10.1016/j.cell.2019.10.038 |
0.361 |
|
| 2019 |
Yu MC, Liu JX, Ma XL, Fu PY, Sun HX, Tang WG, Yang ZF, Qiu SJ, Zhou J, Fan J, Xu Y. Differential network analysis depicts regulatory mechanisms for hepatocellular carcinoma from diverse backgrounds. Future Oncology (London, England). PMID 31729887 DOI: 10.2217/Fon-2019-0275 |
0.37 |
|
| 2019 |
Fu PY, Hu B, Ma XL, Tang WG, Yang ZF, Sun HX, Yu MC, Huang A, Hu JW, Zhou CH, Fan J, Xu Y, Zhou J. Far Upstream Element-Binding Protein 1 Facilitates Hepatocellular Carcinoma Invasion and Metastasis. Carcinogenesis. PMID 31587040 DOI: 10.1093/Carcin/Bgz171 |
0.401 |
|
| 2019 |
Gao Q, Zhu H, Dong L, Shi W, Chen R, Song Z, Huang C, Li J, Dong X, Zhou Y, Liu Q, Ma L, Wang X, Zhou J, Liu Y, ... ... Fan J, et al. Integrated Proteogenomic Characterization of HBV-Related Hepatocellular Carcinoma. Cell. 179: 561-577.e22. PMID 31585088 DOI: 10.1016/J.Cell.2019.08.052 |
0.399 |
|
| 2019 |
Fu XT, Tang Z, Shi YH, Zhou J, Liu WR, Gao Q, Ding GY, Chen JF, Song K, Wang XY, Fan J, Ding ZB. Laparoscopic Versus Open Left Lateral Segmentectomy for Large Hepatocellular Carcinoma: A Propensity Score-Matched Analysis. Surgical Laparoscopy, Endoscopy & Percutaneous Techniques. PMID 31568257 DOI: 10.1097/Sle.0000000000000723 |
0.337 |
|
| 2019 |
Gao Y, Wang PX, Cheng JW, Sun YF, Hu B, Guo W, Zhou KQ, Yin Y, Li YC, Wang J, Huang JF, Qiu SJ, Zhou J, Fan J, Yang XR. Chemotherapeutic perfusion of portal vein after tumor thrombectomy and hepatectomy benefits patients with advanced hepatocellular carcinoma: A propensity score-matched survival analysis. Cancer Medicine. PMID 31566899 DOI: 10.1002/Cam4.2556 |
0.429 |
|
| 2019 |
Zhu K, Zhan H, Peng Y, Yang L, Gao Q, Jia H, Dai Z, Tang Z, Fan J, Zhou J. Plasma hsa_circ_0027089 is a diagnostic biomarker for hepatitis B virus-related hepatocellular carcinoma. Carcinogenesis. PMID 31535687 DOI: 10.1093/Carcin/Bgz154 |
0.369 |
|
| 2019 |
Zhu K, Peng Y, Hu J, Zhan H, Yang L, Gao Q, Jia H, Luo R, Dai Z, Tang Z, Fan J, Zhou J. Metadherin-PRMT5 complex enhances the metastasis of hepatocellular carcinoma through the WNT-β-catenin signaling pathway. Carcinogenesis. PMID 31498866 DOI: 10.1093/Carcin/Bgz065 |
0.36 |
|
| 2019 |
Zhou C, Zhang X, Peng Y, Zhou K, Hu J, Yu L, Chen F, Qiu S, Zhou J, Fan J, Zhang L, Wang Z. Surgical Resection plus Radiofrequency Ablation versus Radical Surgery for Hepatocellular Carcinoma: A Propensity Score Matching Analysis. Journal of Cancer. 10: 3933-3940. PMID 31417637 DOI: 10.7150/Jca.29501 |
0.346 |
|
| 2019 |
Hu B, Cheng JW, Hu JW, Li H, Ma XL, Tang WG, Sun YF, Guo W, Huang A, Zhou KQ, Gao PT, Cao Y, Qiu SJ, Zhou J, Fan J, et al. KPNA3 Confers Sorafenib Resistance to Advanced Hepatocellular Carcinoma via TWIST Regulated Epithelial-Mesenchymal Transition. Journal of Cancer. 10: 3914-3925. PMID 31417635 DOI: 10.7150/Jca.31448 |
0.374 |
|
| 2019 |
Ma XL, Sun YF, Wang BL, Shen MN, Zhou Y, Chen JW, Hu B, Gong ZJ, Zhang X, Cao Y, Pan BS, Zhou J, Fan J, Guo W, Yang XR. Sphere-forming culture enriches liver cancer stem cells and reveals Stearoyl-CoA desaturase 1 as a potential therapeutic target. Bmc Cancer. 19: 760. PMID 31370822 DOI: 10.1186/S12885-019-5963-Z |
0.332 |
|
| 2019 |
Cai J, Chen L, Zhang Z, Zhang X, Lu X, Liu W, Shi G, Ge Y, Gao P, Yang Y, Ke A, Xiao L, Dong R, Zhu Y, Yang X, ... ... Fan J, et al. Genome-wide mapping of 5-hydroxymethylcytosines in circulating cell-free DNA as a non-invasive approach for early detection of hepatocellular carcinoma. Gut. PMID 31358576 DOI: 10.1136/Gutjnl-2019-318882 |
0.367 |
|
| 2019 |
Zhou SL, Zhou ZJ, Hu ZQ, Song CL, Luo YJ, Luo CB, Xin HY, Yang XR, Shi YH, Wang Z, Huang XW, Cao Y, Fan J, Zhou J. Genomic Sequencing Identifies WNK2 as a Driver in hepatocellular carcinoma and a Risk Factor for Early Recurrence. Journal of Hepatology. PMID 31349001 DOI: 10.1016/J.Jhep.2019.07.014 |
0.397 |
|
| 2019 |
Hu B, Li H, Guo W, Sun YF, Zhang X, Tang WG, Yang LX, Xu Y, Tang XY, Ding GH, Qiu SJ, Zhou J, Li YX, Fan J, Yang XR. Establishment of a hepatocellular carcinoma patient-derived xenograft platform and its application in biomarker identification. International Journal of Cancer. PMID 31310010 DOI: 10.1002/Ijc.32564 |
0.414 |
|
| 2019 |
Miao B, Wei C, Qiao Z, Han W, Chai X, Lu J, Gao C, Dong R, Gao D, Huang C, Ke A, Zhou J, Fan J, Shi G, Lan F, et al. eIF3a mediates HIF1α-dependent glycolytic metabolism in hepatocellular carcinoma cells through translational regulation. American Journal of Cancer Research. 9: 1079-1090. PMID 31218114 |
0.394 |
|
| 2019 |
Zhu GQ, Yang Y, Chen EB, Wang B, Xiao K, Shi SM, Zhou ZJ, Zhou SL, Wang Z, Shi YH, Fan J, Zhou J, Liu TS, Dai Z. Development and validation of a new tumor-based gene signature predicting prognosis of HBV/HCV-included resected hepatocellular carcinoma patients. Journal of Translational Medicine. 17: 203. PMID 31215439 DOI: 10.1186/S12967-019-1946-8 |
0.421 |
|
| 2019 |
Wang W, Cheng J, Qin JJ, Hu B, Li X, Nijampatnam B, Velu SE, Fan J, Yang XR, Zhang R. MDM2-NFAT1 Dual Inhibitor, MA242: Effective against Hepatocellular Carcinoma, Independent of p53. Cancer Letters. 114429. PMID 31181320 DOI: 10.1016/J.Canlet.2019.114429 |
0.404 |
|
| 2019 |
Tian MX, Liu WR, Wang H, Zhou YF, Jin L, Jiang XF, Tao CY, Tang Z, Zhou PY, Fang Y, Qu WF, Ding ZB, Peng YF, Dai Z, Qiu SJ, ... ... Fan J, et al. Tissue-infiltrating lymphocytes signature predicts survival in patients with early/intermediate stage hepatocellular carcinoma. Bmc Medicine. 17: 106. PMID 31164128 DOI: 10.1186/S12916-019-1341-6 |
0.389 |
|
| 2019 |
Zhang PF, Wei CY, Huang XY, Peng R, Yang X, Lu JC, Zhang C, Gao C, Cai JB, Gao PT, Gao DM, Shi GM, Ke AW, Fan J. Circular RNA circTRIM33-12 acts as the sponge of MicroRNA-191 to suppress hepatocellular carcinoma progression. Molecular Cancer. 18: 105. PMID 31153371 DOI: 10.1186/s12943-019-1031-1 |
0.383 |
|
| 2019 |
Tian M, Shi Y, Liu W, Fan J. Immunotherapy of hepatocellular carcinoma: strategies for combinatorial intervention. Science China. Life Sciences. PMID 31119560 DOI: 10.1007/s11427-018-9446-2 |
0.432 |
|
| 2019 |
Zhu GQ, Zhou YJ, Qiu LX, Wang B, Yang Y, Liao WT, Luo YH, Shi YH, Zhou J, Fan J, Dai Z. Prognostic alternative mRNA splicing signature in hepatocellular carcinoma: a study based on large-scale sequencing data. Carcinogenesis. PMID 31099827 DOI: 10.1093/Carcin/Bgz073 |
0.404 |
|
| 2019 |
Yang Y, Chen Q, Piao HY, Wang B, Zhu GQ, Chen EB, Xiao K, Zhou ZJ, Shi GM, Shi YH, Wu WZ, Fan J, Zhou J, Dai Z. HNRNPAB-regulated lncRNA-ELF209 inhibits the malignancy of hepatocellular carcinoma. International Journal of Cancer. PMID 31090062 DOI: 10.1002/Ijc.32409 |
0.374 |
|
| 2019 |
Yang X, Miao BS, Wei CY, Dong RZ, Gao PT, Zhang XY, Lu JC, Gao C, Wang XY, Sun HC, Zhou J, Fan J, Ke AW, Shi GM, Cai JB. LSH promotes the growth and invasion of HCC via transcriptional regulation of CENPF expression. Cancer Science. PMID 31066149 DOI: 10.1111/Cas.14037 |
0.421 |
|
| 2019 |
Ma XL, Shen MN, Hu B, Wang BL, Yang WJ, Lv LH, Wang H, Zhou Y, Jin AL, Sun YF, Zhang CY, Qiu SJ, Pan BS, Zhou J, Fan J, et al. CD73 promotes hepatocellular carcinoma progression and metastasis via activating PI3K/AKT signaling by inducing Rap1-mediated membrane localization of P110β and predicts poor prognosis. Journal of Hematology & Oncology. 12: 37. PMID 30971294 DOI: 10.1186/S13045-019-0724-7 |
0.39 |
|
| 2019 |
Fu XT, Song K, Zhou J, Shi YH, Liu WR, Shi GM, Gao Q, Wang XY, Ding ZB, Fan J. Tumor-associated macrophages modulate resistance to oxaliplatin via inducing autophagy in hepatocellular carcinoma. Cancer Cell International. 19: 71. PMID 30962765 DOI: 10.1186/S12935-019-0771-8 |
0.362 |
|
| 2019 |
Zhou SL, Yin D, Hu ZQ, Luo CB, Zhou ZJ, Xin HY, Yang XR, Shi YH, Wang Z, Huang XW, Cao Y, Fan J, Zhou J. A Positive Feedback Loop between Cancer Stem-Like Cells and Tumor- Associated Neutrophils Controls Hepatocellular Carcinoma Progression. Hepatology (Baltimore, Md.). PMID 30933361 DOI: 10.1002/Hep.30630 |
0.417 |
|
| 2019 |
Zhou C, Peng Y, Zhou K, Zhang L, Zhang X, Yu L, Hu J, Chen F, Qiu S, Zhou J, Fan J, Ren Z, Wang Z. Surgical resection plus radiofrequency ablation for the treatment of multifocal hepatocellular carcinoma. Hepatobiliary Surgery and Nutrition. 8: 19-28. PMID 30881962 DOI: 10.21037/Hbsn.2018.11.19 |
0.389 |
|
| 2019 |
Li XL, Zhu XD, Cai H, Li Y, Zhou J, Fan J, Tang ZY, Sun HC. Postoperative α-fetoprotein response predicts tumor recurrence and survival after hepatectomy for hepatocellular carcinoma: A propensity score matching analysis. Surgery. PMID 30846192 DOI: 10.1016/J.Surg.2019.01.009 |
0.352 |
|
| 2019 |
Xie DY, Fan HK, Ren ZG, Fan J, Gao Q. Identifying Clonal Origin of Multifocal Hepatocellular Carcinoma and Its Clinical Implications. Clinical and Translational Gastroenterology. 10: e00006. PMID 30829920 DOI: 10.14309/ctg.0000000000000006 |
0.423 |
|
| 2019 |
Jiang Y, Sun A, Zhao Y, Ying W, Sun H, Yang X, Xing B, Sun W, Ren L, Hu B, Li C, Zhang L, Qin G, Zhang M, Chen N, ... ... Fan J, et al. Proteomics identifies new therapeutic targets of early-stage hepatocellular carcinoma. Nature. PMID 30814741 DOI: 10.1038/S41586-019-0987-8 |
0.377 |
|
| 2019 |
He J, Zuo Q, Hu B, Jin H, Wang C, Cheng Z, Deng X, Yang C, Ruan H, Yu C, Zhao F, Yao M, Fang J, Gu J, Zhou J, ... Fan J, et al. A novel, liver-specific long noncoding RNA LINC01093 suppresses HCC progression by interaction with IGF2BP1 to facilitate decay of GLI1 mRNA. Cancer Letters. PMID 30790682 DOI: 10.1016/J.Canlet.2019.02.033 |
0.421 |
|
| 2019 |
Duan M, Goswami S, Shi JY, Wu LJ, Wang XY, Ma JQ, Zhang Z, Shi Y, Ma LJ, Zhang S, Xi R, Cao Y, Zhou J, Fan J, Zhang XM, et al. Activated and Exhausted MAIT Cells Foster Disease Progression and Indicate Poor Outcome in Hepatocellular Carcinoma. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 30723143 DOI: 10.1158/1078-0432.Ccr-18-3040 |
0.356 |
|
| 2019 |
Zhao X, Reebye V, Hitchen P, Fan J, Jiang H, Sætrom P, Rossi J, Habib NA, Huang KW. Mechanisms involved in the activation of C/EBPα by small activating RNA in hepatocellular carcinoma. Oncogene. PMID 30643190 DOI: 10.1038/S41388-018-0665-6 |
0.326 |
|
| 2018 |
Liu S, Li H, Guo L, Zhang B, Zhou B, Zhang W, Zhou J, Fan J, Ye Q. Tumor Size Affects Efficacy of Adjuvant Transarterial Chemoembolization in Patients with Hepatocellular Carcinoma and Microvascular Invasion. The Oncologist. PMID 30552155 DOI: 10.1634/Theoncologist.2018-0305 |
0.429 |
|
| 2018 |
Yang X, Cai JB, Peng R, Wei CY, Lu JC, Gao C, Shen ZZ, Zhang PF, Huang XY, Ke AW, Shi GM, Fan J. The long noncoding RNA NORAD enhances the TGF-β pathway to promote hepatocellular carcinoma progression by targeting miR-202-5p. Journal of Cellular Physiology. PMID 30537113 DOI: 10.1002/jcp.27869 |
0.379 |
|
| 2018 |
Shi DM, Li LX, Bian XY, Shi XJ, Lu LL, Zhou HX, Pan TJ, Zhou J, Fan J, Wu WZ. miR-296-5p suppresses EMT of hepatocellular carcinoma via attenuating NRG1/ERBB2/ERBB3 signaling. Journal of Experimental & Clinical Cancer Research : Cr. 37: 294. PMID 30486894 DOI: 10.1186/S13046-018-0957-2 |
0.311 |
|
| 2018 |
Gan W, Zhang MX, Wang JX, Fu YP, Huang JL, Yi Y, Jing CY, Fan J, Zhou J, Qiu SJ. Prognostic impact of lactic dehydrogenase to albumin ratio in hepatocellular carcinoma patients with Child-Pugh I who underwent curative resection: a prognostic nomogram study. Cancer Management and Research. 10: 5383-5394. PMID 30464634 DOI: 10.2147/CMAR.S176317 |
0.422 |
|
| 2018 |
Zheng BH, Liu LZ, Zhang ZZ, Shi JY, Dong LQ, Tian LY, Ding ZB, Ji Y, Rao SX, Zhou J, Fan J, Wang XY, Gao Q. Radiomics score: a potential prognostic imaging feature for postoperative survival of solitary HCC patients. Bmc Cancer. 18: 1148. PMID 30463529 DOI: 10.1186/S12885-018-5024-Z |
0.375 |
|
| 2018 |
Dong L, Zhou H, Zhao M, Gao X, Liu Y, Liu D, Guo W, Hu H, Xie Q, Fan J, Lin J, Wu W. Phosphorothioate-Modified AP613-1 Specifically Targets GPC3 when Used for Hepatocellular Carcinoma Cell Imaging. Molecular Therapy. Nucleic Acids. 13: 376-386. PMID 30347351 DOI: 10.1016/j.omtn.2018.09.013 |
0.338 |
|
| 2018 |
Zhou J, Sun HC, Wang Z, Cong WM, Wang JH, Zeng MS, Yang JM, Bie P, Liu LX, Wen TF, Han GH, Wang MQ, Liu RB, Lu LG, Ren ZG, ... ... Fan J, et al. Guidelines for Diagnosis and Treatment of Primary Liver Cancer in China (2017 Edition). Liver Cancer. 7: 235-260. PMID 30319983 DOI: 10.1159/000488035 |
0.363 |
|
| 2018 |
Sun QM, Hu B, Fu PY, Tang WG, Zhang X, Zhan H, Sun C, He YF, Song K, Xiao YS, Sun J, Xu Y, Zhou J, Fan J. Long non-coding RNA00607 as a tumor suppressor by modulating NF-κB p65/p53 signaling axis in hepatocellular carcinoma. Carcinogenesis. PMID 30169594 DOI: 10.1093/Carcin/Bgy113 |
0.402 |
|
| 2018 |
Liu LZ, Zhang Z, Zheng BH, Shi Y, Duan M, Ma LJ, Wang ZC, Dong LQ, Dong PP, Shi JY, Zhang S, Ding ZB, Ke AW, Cao Y, Zhang XM, ... ... Fan J, et al. CCL15 recruits suppressive monocytes to facilitate immune escape and disease progression in hepatocellular carcinoma. Hepatology (Baltimore, Md.). PMID 30070719 DOI: 10.1002/Hep.30134 |
0.38 |
|
| 2018 |
Gao PT, Ding GY, Yang X, Dong RZ, Hu B, Zhu XD, Cai JB, Ji Y, Shi GM, Shen YH, Zhou J, Fan J, Sun HC, Huang C. Invasive potential of hepatocellular carcinoma is enhanced by loss of selenium-binding protein 1 and subsequent upregulation of CXCR4. American Journal of Cancer Research. 8: 1040-1049. PMID 30034941 |
0.412 |
|
| 2018 |
Wang Z, Peng Y, Hu J, Wang X, Sun H, Sun J, Shi Y, Xiao Y, Ding Z, Yang X, Tang M, Tang Z, Wang J, Lau WY, Fan J, et al. Associating Liver Partition and Portal Vein Ligation for Staged Hepatectomy for Unresectable Hepatitis B Virus-related Hepatocellular Carcinoma: A Single Center Study of 45 Patients. Annals of Surgery. PMID 29995681 DOI: 10.1097/Sla.0000000000002942 |
0.355 |
|
| 2018 |
Fu XT, Song K, Zhou J, Shi YH, Liu WR, Tian MX, Jin L, Shi GM, Gao Q, Ding ZB, Fan J. Autophagy activation contributes to glutathione transferase Mu 1-mediated chemoresistance in hepatocellular carcinoma. Oncology Letters. 16: 346-352. PMID 29928420 DOI: 10.3892/Ol.2018.8667 |
0.367 |
|
| 2018 |
Ma XL, Zhu J, Wu J, Tian L, Gao YY, Zhang CY, Zhou Y, Dai Q, Wang BL, Pan BS, Zhou J, Fan J, Yang XR, Guo W. Significance of PIVKA-II levels for predicting microvascular invasion and tumor cell proliferation in Chinese patients with hepatitis B virus-associated hepatocellular carcinoma. Oncology Letters. 15: 8396-8404. PMID 29805574 DOI: 10.3892/Ol.2018.8375 |
0.367 |
|
| 2018 |
Luo C, Yin D, Zhan H, Borjigin U, Li C, Zhou Z, Hu Z, Wang P, Sun Q, Fan J, Zhou J, Wang X, Zhou S, Huang X. microRNA-501-3p suppresses metastasis and progression of hepatocellular carcinoma through targeting LIN7A. Cell Death & Disease. 9: 535. PMID 29749382 DOI: 10.1038/S41419-018-0577-Y |
0.341 |
|
| 2018 |
Liu S, Guo L, Li H, Zhang B, Sun J, Zhou C, Zhou J, Fan J, Ye Q. Postoperative Adjuvant Trans-Arterial Chemoembolization for Patients with Hepatocellular Carcinoma and Portal Vein Tumor Thrombus. Annals of Surgical Oncology. PMID 29728879 DOI: 10.1245/S10434-018-6438-1 |
0.387 |
|
| 2018 |
Li Z, Zhang J, Liu X, Li S, Wang Q, Di Chen, Hu Z, Yu T, Ding J, Li J, Yao M, Fan J, Huang S, Gao Q, Zhao Y, et al. The LINC01138 drives malignancies via activating arginine methyltransferase 5 in hepatocellular carcinoma. Nature Communications. 9: 1572. PMID 29679004 DOI: 10.1038/s41467-018-04006-0 |
0.405 |
|
| 2018 |
Ma XL, Jiang M, Zhao Y, Wang BL, Shen MN, Zhou Y, Zhang CY, Sun YF, Chen JW, Hu B, Gong ZJ, Zhang X, Cao Y, Pan BS, Zhou J, ... Fan J, et al. Application of Serum Annexin A3 in Diagnosis, Outcome Prediction and Therapeutic Response Evaluation for Patients with Hepatocellular Carcinoma. Annals of Surgical Oncology. PMID 29626309 DOI: 10.1245/S10434-018-6402-0 |
0.344 |
|
| 2018 |
Gan W, Huang JL, Zhang MX, Fu YP, Yi Y, Jing CY, Fan J, Zhou J, Qiu SJ. New nomogram predicts the recurrence of hepatocellular carcinoma in patients with negative preoperative serum AFP subjected to curative resection. Journal of Surgical Oncology. PMID 29572833 DOI: 10.1002/jso.25046 |
0.391 |
|
| 2018 |
Zhai XF, Liu XL, Shen F, Fan J, Ling CQ. Traditional herbal medicine prevents postoperative recurrence of small hepatocellular carcinoma: A randomized controlled study. Cancer. PMID 29499082 DOI: 10.1002/cncr.30915 |
0.312 |
|
| 2018 |
Wang M, Zhang L, Liu Z, Zhou J, Pan Q, Fan J, Zang R, Wang L. AGO1 may influence the prognosis of hepatocellular carcinoma through TGF-β pathway. Cell Death & Disease. 9: 324. PMID 29487329 DOI: 10.1038/S41419-018-0338-Y |
0.39 |
|
| 2018 |
Hu B, Ding GY, Fu PY, Zhu XD, Ji Y, Shi GM, Shen YH, Cai JB, Yang Z, Zhou J, Fan J, Sun HC, Kuang M, Huang C. NOD-like receptor X1 functions as a tumor suppressor by inhibiting epithelial-mesenchymal transition and inducing aging in hepatocellular carcinoma cells. Journal of Hematology & Oncology. 11: 28. PMID 29482578 DOI: 10.1186/S13045-018-0573-9 |
0.354 |
|
| 2018 |
Zhou J, Wang Z, Ren Z, Chen Y, Hu J, Yang GH, Yu L, Yang XR, Huang A, Zhang X, Zhou SL, Sun HC, Wang YH, Ge NL, Xu XY, ... ... Fan J, et al. Adjuvant transarterial chemoembolization for HBV-related hepatocellular carcinoma after resection: a randomized controlled study. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 29420221 DOI: 10.1158/1078-0432.Ccr-17-2899 |
0.424 |
|
| 2018 |
Zhang B, Zhang B, Zhang Z, Huang Z, Chen Y, Chen M, Bie P, Peng B, Wu L, Wang Z, Li B, Fan J, Qin L, Chen P, Liu J, et al. 42,573 cases of hepatectomy in China: a multicenter retrospective investigation. Science China. Life Sciences. PMID 29417360 DOI: 10.1007/s11427-017-9259-9 |
0.386 |
|
| 2018 |
Fan J, Guo W, Sun YF, Shen M, Ma XL, Wu J, Zhang C, Zhou Y, Xu Y, Hu B, Zhang M, Wang G, Chen WQ, Guo L, Lu R, et al. Circulating tumor cells with stem-like phenotypes for diagnosis, prognosis and therapeutic response evaluation in hepatocellular carcinoma. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 29374055 DOI: 10.1158/1078-0432.CCR-17-1753 |
0.382 |
|
| 2018 |
Duan M, Hao J, Cui S, Worthley DL, Zhang S, Wang Z, Shi J, Liu L, Wang X, Ke A, Cao Y, Xi R, Zhang X, Zhou J, Fan J, et al. Diverse modes of clonal evolution in HBV-related hepatocellular carcinoma revealed by single-cell genome sequencing. Cell Research. PMID 29327728 DOI: 10.1038/Cr.2018.11 |
0.403 |
|
| 2018 |
Gan W, Yi Y, Fu Y, Huang J, Lu Z, Jing C, Fan J, Zhou J, Qiu S. Fibrinogen and C-reactive protein score is a prognostic index for patients with hepatocellular carcinoma undergoing curative resection: a prognostic nomogram study. Journal of Cancer. 9: 148-156. PMID 29290780 DOI: 10.7150/jca.22246 |
0.353 |
|
| 2017 |
Zhan H, Jiang J, Sun Q, Ke A, Hu J, Hu Z, Zhu K, Luo C, Ren N, Fan J, Zhou J, Huang X. Whole-Exome Sequencing-Based Mutational Profiling of Hepatitis B Virus-Related Early-Stage Hepatocellular Carcinoma. Gastroenterology Research and Practice. 2017: 2029315. PMID 29333154 DOI: 10.1155/2017/2029315 |
0.375 |
|
| 2017 |
Xie DY, Ren ZG, Zhou J, Fan J, Gao Q. Critical appraisal of Chinese 2017 guideline on the management of hepatocellular carcinoma. Hepatobiliary Surgery and Nutrition. 6: 387-396. PMID 29312973 DOI: 10.21037/Hbsn.2017.11.01 |
0.378 |
|
| 2017 |
Gao PT, Cheng JW, Gong ZJ, Hu B, Sun YF, Cao Y, Qiu SJ, Zhou J, Fan J, Yang XR. Low SLC29A1 expression is associated with poor prognosis in patients with hepatocellular carcinoma. American Journal of Cancer Research. 7: 2465-2477. PMID 29312800 |
0.434 |
|
| 2017 |
Tang WG, Hu B, Sun HX, Sun QM, Sun C, Fu PY, Yang ZF, Zhang X, Zhou CH, Fan J, Ren N, Xu Y. Long non-coding RNA00364 represses hepatocellular carcinoma cell proliferation via modulating p-STAT3-IFIT2 signaling axis. Oncotarget. 8: 102006-102019. PMID 29254221 DOI: 10.18632/oncotarget.22039 |
0.413 |
|
| 2017 |
Chen XX, Cheng JW, Huang A, Zhang X, Wang J, Fan J, Zhou J, Yang XR. The effect of antiviral therapy on patients with hepatitis B virus-related hepatocellular carcinoma after curative resection: a systematic review and meta-analysis. Oncotargets and Therapy. 10: 5363-5375. PMID 29180870 DOI: 10.2147/Ott.S150281 |
0.357 |
|
| 2017 |
Huang JL, Fu YP, Jing CY, Yi Y, Sun J, Gan W, Lu ZF, Zhou J, Fan J, Qiu SJ. A novel and validated prognostic nomogram based on liver fibrosis and tumor burden for patients with hepatocellular carcinoma after curative resection. Journal of Surgical Oncology. PMID 29165812 DOI: 10.1002/jso.24895 |
0.383 |
|
| 2017 |
Dong ZR, Zou J, Sun D, Shi GM, Ke AW, Cai JB, Sun HC, Qiu SJ, Li T, Zhou J, Zhi XT, Fan J. Preoperative Albumin-Bilirubin Score for Postoperative Solitary Hepatocellular Carcinoma within the Milan Criteria and Child-Pugh A Cirrhosis. Journal of Cancer. 8: 3862-3867. PMID 29151974 DOI: 10.7150/Jca.21313 |
0.39 |
|
| 2017 |
Sun HC, Xie L, Yang XR, Li W, Yu J, Zhu XD, Xia Y, Zhang T, Xu Y, Hu B, Du LP, Zeng LY, Ouyang J, Zhang W, Song TQ, ... ... Fan J, et al. Shanghai Score: A Prognostic and Adjuvant Treatment-evaluating System Constructed for Chinese Patients with Hepatocellular Carcinoma after Curative Resection. Chinese Medical Journal. 130: 2650-2660. PMID 29133751 DOI: 10.4103/0366-6999.218019 |
0.366 |
|
| 2017 |
Sun Y, Guo W, Xu Y, Shi YH, Gong Z, Ji Y, Du M, Zhang X, Hu B, Huang A, Chen GG, Lai PBS, Cao Y, Qiu SJ, Zhou J, ... ... Fan J, et al. Circulating Tumors Cells from Different Vascular Sites Exhibit Spatial Heterogeneity in Epithelial and Mesenchymal Composition and Distinct Clinical Significance in Hepatocellular Carcinoma. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 29070526 DOI: 10.1158/1078-0432.CCR-17-1063 |
0.363 |
|
| 2017 |
Mazzaferro V, Sposito C, Zhou J, Pinna AD, De Carlis L, Fan J, Cescon M, Di Sandro S, Yi-Feng H, Lauterio A, Bongini M, Cucchetti A. Metroticket 2.0 Model for Analysis of Competing Risks of Death Following Liver Transplantation for Hepatocellular Carcinoma. Gastroenterology. PMID 28989060 DOI: 10.1053/J.Gastro.2017.09.025 |
0.377 |
|
| 2017 |
Huang A, Zhao X, Yang XR, Li FQ, Zhou XL, Wu K, Zhang X, Sun QM, Cao Y, Zhu HM, Wang XD, Yang HM, Wang J, Tang ZY, Hou Y, ... Fan J, et al. Corrigendum to "Circumventing intratumoral heterogeneity to identify potential therapeutic targets in hepatocellular carcinoma" [J Hepatol 67 (2017) 293-301]. Journal of Hepatology. PMID 28916407 DOI: 10.1016/J.Jhep.2017.08.003 |
0.334 |
|
| 2017 |
Liu X, Wang Z, Chen Z, Liu L, Ma L, Dong L, Zhang Z, Zhang S, Yang L, Shi J, Fan J, Wang X, Gao Q. Efficacy and Safety of Transcatheter Arterial Chemoembolization and Transcatheter Arterial Chemotherapy Infusion in Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis. Oncology Research. PMID 28911342 DOI: 10.3727/096504017X15051752095738 |
0.315 |
|
| 2017 |
Shi JY, Ma LJ, Zhang JW, Duan M, Ding ZB, Yang LX, Cao Y, Zhou J, Fan J, Zhang X, Zhao YJ, Wang XY, Gao Q. FOXP3 Is a HCC suppressor gene and Acts through regulating the TGF-β/Smad2/3 signaling pathway. Bmc Cancer. 17: 648. PMID 28903735 DOI: 10.1186/S12885-017-3633-6 |
0.38 |
|
| 2017 |
Xu G, Ye J, Liu XJ, Zhang NP, Zhao YM, Fan J, Liu XP, Wu J. Activation of pluripotent genes in hepatic progenitor cells in the transition of nonalcoholic steatohepatitis to pre-malignant lesions. Laboratory Investigation; a Journal of Technical Methods and Pathology. PMID 28869588 DOI: 10.1038/Labinvest.2017.84 |
0.315 |
|
| 2017 |
Ma LJ, Wang XY, Duan M, Liu LZ, Shi JY, Dong LQ, Yang LX, Wang ZC, Ding ZB, Ke AW, Cao Y, Zhang XM, Zhou J, Fan J, Gao Q. Telomere Length Variation in Tumor cells and Cancer-Associated Fibroblasts: Potential Biomarker for Hepatocellular Carcinoma. The Journal of Pathology. PMID 28833123 DOI: 10.1002/Path.4961 |
0.421 |
|
| 2017 |
Liu W, Hu J, Zhou K, Chen F, Wang Z, Liao B, Dai Z, Cao Y, Fan J, Zhou J. Serum exosomal miR-125b is a novel prognostic marker for hepatocellular carcinoma. Oncotargets and Therapy. 10: 3843-3851. PMID 28814883 DOI: 10.2147/Ott.S140062 |
0.318 |
|
| 2017 |
Wang H, Huo X, Yang XR, He J, Cheng L, Wang N, Deng X, Jin H, Wang N, Wang C, Zhao F, Fang J, Yao M, Fan J, Qin W. STAT3-mediated upregulation of lncRNA HOXD-AS1 as a ceRNA facilitates liver cancer metastasis by regulating SOX4. Molecular Cancer. 16: 136. PMID 28810927 DOI: 10.1186/s12943-017-0680-1 |
0.364 |
|
| 2017 |
Jiang J, Hu H, Liu R, Wang JH, Long XR, Fan J, Yan ZP. Nomogram for individualized prediction of recurrence after postoperative adjuvant TACE for hepatitis B virus-related hepatocellular carcinoma. Medicine. 96: e7390. PMID 28796032 DOI: 10.1097/MD.0000000000007390 |
0.364 |
|
| 2017 |
Wang H, Liu W, Tian M, Tang Z, Jiang X, Zhou P, Ding Z, Peng Y, Dai Z, Qiu S, Zhou J, Fan J, Shi Y. Coagulopathy associated with poor prognosis in intrahepatic cholangiocarcinoma patients after curative resection. Bioscience Trends. PMID 28781265 DOI: 10.5582/Bst.2017.01080 |
0.301 |
|
| 2017 |
Ye J, Li TS, Xu G, Zhao YM, Zhang NP, Fan J, Wu J. JCAD Promotes Progression of Non-alcoholic Steatohepatitis to Liver Cancer by Inhibiting LATS2 Kinase Activity. Cancer Research. PMID 28775168 DOI: 10.1158/0008-5472.Can-17-0229 |
0.402 |
|
| 2017 |
Chen Q, Yin D, Zhang Y, Yu L, Li XD, Zhou ZJ, Zhou SL, Gao DM, Hu J, Jin C, Wang Z, Shi YH, Cao Y, Fan J, Dai Z, et al. MicroRNA-29a induces loss of 5-hydroxymethylcytosine and promotes metastasis of hepatocellular carcinoma through a TET-SOCS1-MMP9 signaling axis. Cell Death & Disease. 8: e2906. PMID 28661477 DOI: 10.1038/Cddis.2017.142 |
0.322 |
|
| 2017 |
Tian L, Yu Q, Gao XH, Wu J, Ma XL, Dai Q, Zhang CY, Zhou Y, Zhang YC, Pan BS, Zhou J, Fan J, Yang XR, Guo W. A new use for an old index: preoperative high-density lipoprotein predicts recurrence in patients with hepatocellular carcinoma after curative resections. Lipids in Health and Disease. 16: 123. PMID 28651644 DOI: 10.1186/S12944-017-0509-3 |
0.355 |
|
| 2017 |
Wu J, Ma XL, Tian L, Zhang CY, Wang BL, Hu YY, Gao XH, Zhou Y, Shen MN, Peng YF, Pan BS, Zhou J, Fan J, Yang XR, Guo W. Serum IgG4:IgG Ratio Predicts Recurrence of Patients with Hepatocellular Carcinoma after Curative Resection. Journal of Cancer. 8: 1338-1346. PMID 28638447 DOI: 10.7150/Jca.18030 |
0.316 |
|
| 2017 |
Zhang J, Fan J, Zhou C, Qi Y. miR-363-5p as potential prognostic marker for hepatocellular carcinoma indicated by weighted co-expression network analysis of miRNAs and mRNA. Bmc Gastroenterology. 17: 81. PMID 28637446 DOI: 10.1186/s12876-017-0637-2 |
0.309 |
|
| 2017 |
Fu XT, Shi YH, Zhou J, Peng YF, Liu WR, Shi GM, Gao Q, Wang XY, Song K, Fan J, Ding ZB. Association of hepatitis status with surgical outcomes in patients with dual hepatitis B and C related hepatocellular carcinoma. Infectious Agents and Cancer. 12: 28. PMID 28559922 DOI: 10.1186/S13027-017-0137-6 |
0.305 |
|
| 2017 |
Li X, Chen Q, Yin D, Shi S, Yu L, Zhou S, Chen E, Zhou Z, Shi Y, Fan J, Zhou J, Dai Z. Novel role of semaphorin 3A in the growth and progression of hepatocellular carcinoma. Oncology Reports. PMID 28498470 DOI: 10.3892/Or.2017.5616 |
0.431 |
|
| 2017 |
Wang WM, Xu Y, Wang YH, Sun HX, Sun YF, He YF, Zhu QF, Hu B, Zhang X, Xia JL, Qiu SJ, Zhou J, Yang XR, Fan J. HOXB7 promotes tumor progression via bFGF-induced activation of MAPK/ERK pathway and indicated poor prognosis in hepatocellular carcinoma. Oncotarget. PMID 28454092 DOI: 10.18632/Oncotarget.17004 |
0.435 |
|
| 2017 |
Fu YP, Yi Y, Huang JL, Jing CY, Sun J, Ni XC, Lu ZF, Cao Y, Zhou J, Fan J, Qiu SJ. Prognostic Nomograms Stratify Survival of Patients with Hepatocellular Carcinoma Without Portal Vein Tumor Thrombosis After Curative Resection. The Oncologist. PMID 28438885 DOI: 10.1634/Theoncologist.2016-0231 |
0.422 |
|
| 2017 |
Huang A, Zhao X, Yang XR, Li FQ, Zhou XL, Wu K, Zhang X, Sun QM, Cao Y, Zhu HM, Wang XD, Yang HM, Wang J, Tang ZY, Hou Y, ... Fan J, et al. Circumventing intratumoral heterogeneity to identify potential therapeutic targets in hepatocellular carcinoma. Journal of Hepatology. PMID 28323123 DOI: 10.1016/J.Jhep.2017.03.005 |
0.359 |
|
| 2017 |
Jing CY, Fu YP, Zheng SS, Yi Y, Shen HJ, Huang JL, Xu X, Lin JJ, Zhou J, Fan J, Ren ZG, Qiu SJ, Zhang BH. Prognostic nomogram for patients with hepatocellular carcinoma underwent adjuvant transarterial chemoembolization following curative resection. Medicine. 96: e6140. PMID 28296727 DOI: 10.1097/Md.0000000000006140 |
0.376 |
|
| 2017 |
Ge Z, Cheng Z, Yang X, Huo X, Wang N, Wang H, Wang C, Gu D, Zhao F, Yao M, Fan J, Qin W. The long noncoding RNA SchLAH suppresses metastasis of hepatocellular carcinoma through interacting with FUS. Cancer Science. PMID 28196303 DOI: 10.1111/cas.13200 |
0.4 |
|
| 2017 |
Huang C, Zhu XD, Ji Y, Ding GY, Shi GM, Shen YH, Zhou J, Fan J, Sun HC. Microvascular invasion has limited clinical values in hepatocellular carcinoma patients at Barcelona Clinic Liver Cancer (BCLC) stages 0 or B. Bmc Cancer. 17: 58. PMID 28095820 DOI: 10.1186/s12885-017-3050-x |
0.416 |
|
| 2017 |
Yue X, Ai J, Xu Y, Chen Y, Huang M, Yang X, Hu B, Zhang H, He C, Yang X, Tang W, Peng X, Dong L, Wang H, Fan J, et al. Polymeric immunoglobulin receptor promotes tumor growth in hepatocellular carcinoma. Hepatology (Baltimore, Md.). PMID 28073159 DOI: 10.1002/Hep.29036 |
0.367 |
|
| 2016 |
Jin L, Liu WR, Tian MX, Jiang XF, Wang H, Zhou PY, Ding ZB, Peng YF, Dai Z, Qiu SJ, Zhou J, Fan J, Shi YH. CCL24 contributes to HCC malignancy via RhoB- VEGFA-VEGFR2 angiogenesis pathway and indicates poor prognosis. Oncotarget. PMID 28042950 DOI: 10.18632/Oncotarget.14095 |
0.407 |
|
| 2016 |
Hu H, Liu R, Long XR, Han XK, Fan J, Yan ZP, Wang JH. Postsurgical treatment with adjuvant transarterial chemoembolization in patients with hepatitis B-related hepatocellular carcinoma: A strobe-compliant article. Medicine. 95: e5517. PMID 28033246 DOI: 10.1097/MD.0000000000005517 |
0.306 |
|
| 2016 |
Xiang ZL, Zhao XM, Zhang L, Yang P, Fan J, Tang ZY, Zeng ZC. MicroRNA-34a expression levels in serum and intratumoral tissue can predict bone metastasis in patients with hepatocellular carcinoma. Oncotarget. PMID 27893432 DOI: 10.18632/oncotarget.13531 |
0.325 |
|
| 2016 |
Ding ZB, Fu XT, Shi YH, Zhou J, Peng YF, Liu WR, Shi GM, Gao Q, Wang XY, Song K, Jin L, Tian MX, Shen YH, Fan J. Lamp2a is required for tumor growth and promotes tumor recurrence of hepatocellular carcinoma. International Journal of Oncology. PMID 27840904 DOI: 10.3892/Ijo.2016.3754 |
0.446 |
|
| 2016 |
Gong ZJ, Guo W, Sun YF, Zhang X, Qiu SJ, Zhou J, Fan J, Yang XR. Prognostic value of fever grade combined with neutrophil percentage in hepatocellular carcinoma patients presenting fever as the initial manifestation. Oncotargets and Therapy. 9: 6281-6290. PMID 27789960 DOI: 10.2147/Ott.S109023 |
0.396 |
|
| 2016 |
Gao XH, Tian L, Wu J, Ma XL, Zhang CY, Zhou Y, Sun YF, Hu B, Qiu SJ, Zhou J, Fan J, Guo W, Yang XR. Circulating CD14(+) HLA-DR(-/low) myeloid-derived suppressor cells predicted early recurrence of hepatocellular carcinoma after surgery. Hepatology Research : the Official Journal of the Japan Society of Hepatology. PMID 27764536 DOI: 10.1111/Hepr.12831 |
0.413 |
|
| 2016 |
Huang A, Zhang X, Zhou SL, Cao Y, Huang XW, Fan J, Yang XR, Zhou J. Detecting Circulating Tumor DNA in Hepatocellular Carcinoma Patients Using Droplet Digital PCR Is Feasible and Reflects Intratumoral Heterogeneity. Journal of Cancer. 7: 1907-1914. PMID 27698932 DOI: 10.7150/Jca.15823 |
0.323 |
|
| 2016 |
Huang A, Zhang X, Zhou SL, Cao Y, Huang XW, Fan J, Yang XR, Zhou J. Plasma Circulating Cell-free DNA Integrity as a Promising Biomarker for Diagnosis and Surveillance in Patients with Hepatocellular Carcinoma. Journal of Cancer. 7: 1798-1803. PMID 27698918 DOI: 10.7150/Jca.15618 |
0.388 |
|
| 2016 |
Liu Y, Liu DL, Dong LL, Wen D, Shi DM, Zhou J, Fan J, Wu WZ. miR-612 suppresses stem cell-like property of hepatocellular carcinoma cells by modulating Sp1/Nanog signaling. Cell Death & Disease. 7: e2377. PMID 27685621 DOI: 10.1038/Cddis.2016.282 |
0.319 |
|
| 2016 |
Ma XL, Gao XH, Gong ZJ, Wu J, Tian L, Zhang CY, Zhou Y, Sun YF, Hu B, Qiu SJ, Zhou J, Fan J, Guo W, Yang XR. Apolipoprotein A1: a novel serum biomarker for predicting the prognosis of hepatocellular carcinoma after curative resection. Oncotarget. PMID 27683106 DOI: 10.18632/Oncotarget.12203 |
0.37 |
|
| 2016 |
Liao R, Fu YP, Wang T, Deng ZG, Li DW, Fan J, Zhou J, Feng GS, Qiu SJ, Du CY. Metavir and FIB-4 scores are associated with patient prognosis after curative hepatectomy in hepatitis B virus-related hepatocellular carcinoma: a retrospective cohort study at two centers in China. Oncotarget. PMID 27662665 DOI: 10.18632/Oncotarget.12152 |
0.402 |
|
| 2016 |
Gao Q, Wang ZC, Duan M, Lin YH, Zhou XY, Worthley DL, Wang XY, Niu G, Xia Y, Deng M, Liu LZ, Shi JY, Yang LX, Zhang S, Ding ZB, ... ... Fan J, et al. Cell Culture System for Analysis of Genetic Heterogeneity Within Hepatocellular Carcinomas and Response to Pharmacologic Agents. Gastroenterology. PMID 27639803 DOI: 10.1053/J.Gastro.2016.09.008 |
0.366 |
|
| 2016 |
Hu H, Han XK, Long XR, Fan J, Yan ZP, Wang JH, Liu R. Prognostic nomogram for post-surgical treatment with adjuvant TACE in hepatitis B virus-related hepatocellular carcinoma. Oncotarget. PMID 27506942 DOI: 10.18632/oncotarget.11078 |
0.371 |
|
| 2016 |
Yang P, Zeng ZC, Wang BL, Zhang JY, Fan J, Zhou J, Hu Y. The Degree of Lipiodol Accumulation Can Be an Indicator of Successful Treatment for Unresectable Hepatocellular Carcinoma (HCC) Patients - in the Case of Transcatheter Arterial Chemoembolization (TACE) and External Beam Radiotherapy (EBRT). Journal of Cancer. 7: 1413-20. PMID 27471557 DOI: 10.7150/Jca.15405 |
0.406 |
|
| 2016 |
Zhou Y, Wang B, Wu J, Zhang C, Zhou Y, Yang X, Zhou J, Guo W, Fan J. Association of preoperative EpCAM Circulating Tumor Cells and peripheral Treg cell levels with early recurrence of hepatocellular carcinoma following radical hepatic resection. Bmc Cancer. 16: 506. PMID 27439521 DOI: 10.1186/S12885-016-2526-4 |
0.388 |
|
| 2016 |
Hu ZQ, Zhou SL, Zhou ZJ, Luo CB, Chen EB, Zhan H, Wang PC, Dai Z, Zhou J, Fan J, Huang XW. Overexpression of semaphorin 3A promotes tumor progression and predicts poor prognosis in hepatocellular carcinoma after curative resection. Oncotarget. PMID 27351132 DOI: 10.18632/Oncotarget.10104 |
0.364 |
|
| 2016 |
Li T, Wang SK, Zhi XT, Zhou J, Dong ZR, Zhang ZL, Sun HC, Ye QH, Fan J. Cholecystectomy is associated with higher risk of early recurrence and poorer survival after curative resection for early stage hepatocellular carcinoma. Scientific Reports. 6: 28229. PMID 27320390 DOI: 10.1038/Srep28229 |
0.321 |
|
| 2016 |
Li J, Zhou J, Yang PH, Xia Y, Shi YH, Wu D, Lv G, Zheng W, Wang K, Wan XY, Lau WY, Wu MC, Fan J, Shen F. Nomograms for survival prediction in patients undergoing liver resection for hepatitis B virus related early stage hepatocellular carcinoma. European Journal of Cancer (Oxford, England : 1990). 62: 86-95. PMID 27232330 DOI: 10.1016/J.Ejca.2016.04.011 |
0.338 |
|
| 2016 |
Yang SL, Liu LP, Niu L, Sun YF, Yang XR, Fan J, Ren JW, Chen GG, Lai PB. Downregulation and pro-apoptotic effect of hypoxia-inducible factor 2 alpha in hepatocellular carcinoma. Oncotarget. PMID 27119229 DOI: 10.18632/oncotarget.8952 |
0.377 |
|
| 2016 |
Fu YP, Yi Y, Cai XY, Sun J, Ni XC, He HW, Wang JX, Lu ZF, Huang JL, Cao Y, Zhou J, Fan J, Qiu SJ. Overexpression of interleukin-35 associates with hepatocellular carcinoma aggressiveness and recurrence after curative resection. British Journal of Cancer. PMID 27002937 DOI: 10.1038/bjc.2016.47 |
0.387 |
|
| 2016 |
Zhou SL, Zhou ZJ, Hu ZQ, Huang XW, Wang Z, Chen EB, Fan J, Cao Y, Dai Z, Zhou J. Tumor-Associated Neutrophils Recruit Macrophages and T-regulatory Cells to Promote Progression of Hepatocellular Carcinoma and Resistance to Sorafenib. Gastroenterology. PMID 26924089 DOI: 10.1053/J.Gastro.2016.02.040 |
0.347 |
|
| 2016 |
Fu YP, Ni XC, Yi Y, Cai XY, He HW, Wang JX, Lu ZF, Han X, Cao Y, Zhou J, Fan J, Qiu SJ. A Novel and Validated Inflammation-Based Score (IBS) Predicts Survival in Patients With Hepatocellular Carcinoma Following Curative Surgical Resection: A STROBE-Compliant Article. Medicine. 95: e2784. PMID 26886627 DOI: 10.1097/Md.0000000000002784 |
0.364 |
|
| 2016 |
Shi JY, Duan M, Sun QM, Yang L, Wang ZC, Mynbaev OA, He YF, Wang LY, Zhou J, Tang QQ, Cao Y, Fan J, Wang XY, Gao Q. Naive Treg-like CCR7(+) mononuclear cells indicate unfavorable prognosis in hepatocellular carcinoma. Tumour Biology : the Journal of the International Society For Oncodevelopmental Biology and Medicine. PMID 26813566 DOI: 10.1007/S13277-015-4647-9 |
0.33 |
|
| 2016 |
Zhan H, Jiang J, Luo C, Sun Q, Ke A, Sun C, Hu J, Hu Z, Hu B, Zhu K, Fan J, Zhou J, Huang X. Tumour-suppressive role of PTPN13 in hepatocellular carcinoma and its clinical significance. Tumour Biology : the Journal of the International Society For Oncodevelopmental Biology and Medicine. PMID 26801674 DOI: 10.1007/S13277-016-4843-2 |
0.44 |
|
| 2016 |
Gong ZJ, Guo W, Sun YF, Zhang X, Qiu SJ, Zhou J, Fan J, Yang XR. Prognostic value of fever grade combined with neutrophil percentage in hepatocellular carcinoma patients presenting fever as the initial manifestation Oncotargets and Therapy. 9: 6281-6290. DOI: 10.2147/OTT.S109023 |
0.406 |
|
| 2015 |
Shen Q, Yang XR, Tan Y, You H, Xu Y, Chu W, Ge T, Zhou J, Qiu SJ, Shi YH, Zhang Z, Gu J, Wang H, Fan J, Qin W. High level of serum protein DKK1 predicts poor prognosis for patients with hepatocellular carcinoma after hepatectomy. Hepatic Oncology. 2: 231-244. PMID 30191005 DOI: 10.2217/Hep.15.12 |
0.363 |
|
| 2015 |
Shi JY, Xing Q, Duan M, Wang ZC, Yang LX, Zhao YJ, Wang XY, Liu Y, Deng M, Ding ZB, Ke AW, Zhou J, Fan J, Cao Y, Wang J, et al. Inferring the progression of multifocal liver cancer from spatial and temporal genomic heterogeneity. Oncotarget. PMID 26672766 DOI: 10.18632/Oncotarget.6558 |
0.421 |
|
| 2015 |
Yang SL, Liu LP, Sun YF, Yang XR, Fan J, Ren JW, Chen GG, Lai PB. Distinguished prognosis after hepatectomy of HBV-related hepatocellular carcinoma with or without cirrhosis: a long-term follow-up analysis. Journal of Gastroenterology. PMID 26607653 DOI: 10.1007/s00535-015-1146-0 |
0.422 |
|
| 2015 |
Qin M, Liu G, Huo X, Tao X, Sun X, Ge Z, Yang J, Fan J, Liu L, Qin W. Hsa_circ_0001649: A circular RNA and potential novel biomarker for hepatocellular carcinoma. Cancer Biomarkers : Section a of Disease Markers. PMID 26600397 DOI: 10.3233/Cbm-150552 |
0.355 |
|
| 2015 |
Shen Y, Shi G, Huang C, Zhu X, Chen S, Sun H, Zhou J, Fan J. Prediction of Post-Operative Liver Dysfunction by Serum Markers of Liver Fibrosis in Hepatocellular Carcinoma. Plos One. 10: e0140932. PMID 26501145 DOI: 10.1371/Journal.Pone.0140932 |
0.35 |
|
| 2015 |
Hu B, Sun D, Sun C, Sun YF, Sun HX, Zhu QF, Yang XR, Gao YB, Tang WG, Fan J, Maitra A, Anders RA, Xu Y. A polymeric nanoparticle formulation of curcumin in combination with sorafenib synergistically inhibits tumor growth and metastasis in an orthotopic model of human hepatocellular carcinoma. Biochemical and Biophysical Research Communications. PMID 26482853 DOI: 10.1016/j.bbrc.2015.10.031 |
0.415 |
|
| 2015 |
Wan J, Wen D, Dong L, Tang J, Liu D, Liu Y, Tao Z, Gao D, Sun H, Cao Y, Fan J, Wu W. Establishment of monoclonal HCC cell lines with organ site-specific tropisms. Bmc Cancer. 15: 678. PMID 26459277 DOI: 10.1186/s12885-015-1692-0 |
0.397 |
|
| 2015 |
Liao BY, Wang Z, Hu J, Liu WF, Shen ZZ, Zhang X, Yu L, Fan J, Zhou J. PI-88 inhibits postoperative recurrence of hepatocellular carcinoma via disrupting the surge of heparanase after liver resection. Tumour Biology : the Journal of the International Society For Oncodevelopmental Biology and Medicine. PMID 26415733 DOI: 10.1007/S13277-015-4085-8 |
0.445 |
|
| 2015 |
Ni XC, Yi Y, Fu YP, He HW, Cai XY, Wang JX, Zhou J, Cheng YF, Jin JJ, Fan J, Qiu SJ. Prognostic Value of the Modified Glasgow Prognostic Score in Patients Undergoing Radical Surgery for Hepatocellular Carcinoma. Medicine. 94: e1486. PMID 26356714 DOI: 10.1097/Md.0000000000001486 |
0.389 |
|
| 2015 |
Liu WR, Jin L, Tian MX, Jiang XF, Yang LX, Ding ZB, Shen YH, Peng YF, Gao DM, Zhou J, Qiu SJ, Dai Z, Fan J, Shi YH. Caveolin-1 promotes tumor growth and metastasis via autophagy inhibition in hepatocellular carcinoma. Clinics and Research in Hepatology and Gastroenterology. PMID 26206578 DOI: 10.1016/J.Clinre.2015.06.017 |
0.379 |
|
| 2015 |
Tian M, Li Y, Liu W, Jin L, Jiang X, Wang X, Ding Z, Peng Y, Zhou J, Fan J, Cao Y, Wang W, Shi Y. The nanomechanical signature of liver cancer tissues and its molecular origin. Nanoscale. PMID 26168746 DOI: 10.1039/C5Nr02192H |
0.336 |
|
| 2015 |
Zhang X, Yang XR, Sun C, Hu B, Sun YF, Huang XW, Wang Z, He YF, Zeng HY, Qiu SJ, Cao Y, Fan J, Zhou J. Promyelocytic leukemia protein induces arsenic trioxide resistance through regulation of aldehyde dehydrogenase 3 family member A1 in hepatocellular carcinoma. Cancer Letters. 366: 112-22. PMID 26118777 DOI: 10.1016/J.Canlet.2015.06.014 |
0.412 |
|
| 2015 |
Yang H, Peng YF, Ni HM, Li Y, Shi YH, Ding WX, Fan J. Basal Autophagy and Feedback Activation of Akt Are Associated with Resistance to Metformin-Induced Inhibition of Hepatic Tumor Cell Growth. Plos One. 10: e0130953. PMID 26111001 DOI: 10.1371/journal.pone.0130953 |
0.322 |
|
| 2015 |
Li T, Wang SK, Zhou J, Sun HC, Qiu SJ, Ye QH, Wang L, Fan J. Positive HBcAb is associated with higher risk of early recurrence and poorer survival after curative resection of HBV-related HCC. Liver International : Official Journal of the International Association For the Study of the Liver. PMID 26104132 DOI: 10.1111/Liv.12898 |
0.386 |
|
| 2015 |
Tian M, Liu W, Jin L, Jiang X, Yang L, Ding Z, Shen Y, Peng Y, Gao D, Li L, Zhou J, Qiu S, Dai Z, Fan J, Shi Y. LOXL4 is downregulated in hepatocellular carcinoma with a favorable prognosis. International Journal of Clinical and Experimental Pathology. 8: 3892-900. PMID 26097573 |
0.42 |
|
| 2015 |
Qiu SJ, Zhou ZG, Shen F, Li AJ, Chen MS, Ying MG, Chen Z, Zhang YX, Sun HC, Fan J. A multicenter, randomized, observation-controlled clinical trial to evaluate the efficacy and safety of thymalfasin adjuvant therapy in patients with HBV-related HCC after curative resection - first announcement of the protocol. Expert Opinion On Biological Therapy. 15: 133-7. PMID 26094695 DOI: 10.1517/14712598.2015.1039979 |
0.4 |
|
| 2015 |
Wang ZC, Gao Q, Shi JY, Guo WJ, Yang LX, Liu XY, Liu LZ, Ma LJ, Duan M, Zhao YJ, Wu YN, Gao DM, Wang XY, Shi GM, Ding ZB, ... ... Fan J, et al. PTPRS Acts as A Metastatic Suppressor in Hepatocellular Carcinoma by Control of EGFR Induced Epithelial-Mesenchymal Transition. Hepatology (Baltimore, Md.). PMID 25998839 DOI: 10.1002/Hep.27911 |
0.416 |
|
| 2015 |
Yuan SX, Wang J, Yang F, Tao QF, Zhang J, Wang LL, Yang Y, Liu H, Wang ZG, Xu QG, Fan J, Liu L, Sun SH, Zhou WP. Long noncoding RNA DANCR increases stemness features of hepatocellular carcinoma by derepression of CTNNB1. Hepatology (Baltimore, Md.). PMID 25964079 DOI: 10.1002/hep.27893 |
0.35 |
|
| 2015 |
Zhang P, Dong Z, Cai J, Zhang C, Shen Z, Ke A, Gao D, Fan J, Shi G. BRD4 promotes tumor growth and epithelial-mesenchymal transition in hepatocellular carcinoma. International Journal of Immunopathology and Pharmacology. 28: 36-44. PMID 25816404 DOI: 10.1177/0394632015572070 |
0.434 |
|
| 2015 |
Wen D, Liu D, Tang J, Dong L, Liu Y, Tao Z, Wan J, Gao D, Wang L, Sun H, Fan J, Wu W. Malic enzyme 1 induces epithelial-mesenchymal transition and indicates poor prognosis in hepatocellular carcinoma. Tumour Biology : the Journal of the International Society For Oncodevelopmental Biology and Medicine. PMID 25753478 DOI: 10.1007/S13277-015-3306-5 |
0.442 |
|
| 2015 |
Ge T, Shen Q, Wang N, Zhang Y, Ge Z, Chu W, Lv X, Zhao F, Zhao W, Fan J, Qin W. Diagnostic values of alpha-fetoprotein, dickkopf-1, and osteopontin for hepatocellular carcinoma. Medical Oncology (Northwood, London, England). 32: 59. PMID 25652109 DOI: 10.1007/s12032-014-0367-z |
0.407 |
|
| 2015 |
Dong ZR, Zhang PF, Wang CH, Zhang C, Cai JB, Shi GM, Ke AW, Sun HC, Qiu SJ, Zhou J, Fan J. Postoperative adjuvant transcatheter arterial chemoembolization for resectable multiple hepatocellular carcinoma beyond the Milan criteria: a retrospective analysis. American Journal of Cancer Research. 5: 450-7. PMID 25628953 |
0.331 |
|
| 2015 |
Chen Z, Lu X, Wang Z, Jin G, Wang Q, Chen D, Chen T, Li J, Fan J, Cong W, Gao Q, He X. Co-expression of PKM2 and TRIM35 predicts survival and recurrence in hepatocellular carcinoma. Oncotarget. 6: 2538-48. PMID 25576919 |
0.435 |
|
| 2015 |
Cai JB, Shi GM, Dong ZR, Ke AW, Ma HH, Gao Q, Shen ZZ, Huang XY, Chen H, Yu DD, Liu LX, Zhang PF, Zhang C, Hu MY, Yang LX, ... ... Fan J, et al. Ubiquitin-specific protease 7 accelerates p14(ARF) degradation by deubiquitinating thyroid hormone receptor-interacting protein 12 and promotes hepatocellular carcinoma progression. Hepatology (Baltimore, Md.). 61: 1603-14. PMID 25557975 DOI: 10.1002/Hep.27682 |
0.422 |
|
| 2015 |
Liu WR, Tian MX, Yang LX, Lin YL, Jin L, Ding ZB, Shen YH, Peng YF, Gao DM, Zhou J, Qiu SJ, Dai Z, He R, Fan J, Shi YH. PKM2 promotes metastasis by recruiting myeloid-derived suppressor cells and indicates poor prognosis for hepatocellular carcinoma. Oncotarget. 6: 846-61. PMID 25514599 DOI: 10.18632/Oncotarget.2749 |
0.445 |
|
| 2015 |
Zhou SL, Zhou ZJ, Hu ZQ, Li X, Huang XW, Wang Z, Fan J, Dai Z, Zhou J. CXCR2/CXCL5 axis contributes to epithelial-mesenchymal transition of HCC cells through activating PI3K/Akt/GSK-3β/Snail signaling. Cancer Letters. 358: 124-35. PMID 25462858 DOI: 10.1016/J.Canlet.2014.11.044 |
0.405 |
|
| 2015 |
Song J, Ge Z, Yang X, Luo Q, Wang C, You H, Ge T, Deng Y, Lin H, Cui Y, Chu W, Yao M, Zhang Z, Gu J, Fan J, et al. Hepatic stellate cells activated by acidic tumor microenvironment promote the metastasis of hepatocellular carcinoma via osteopontin. Cancer Letters. 356: 713-20. PMID 25449435 DOI: 10.1016/J.Canlet.2014.10.021 |
0.389 |
|
| 2015 |
Gao Q, Wang XY, Zhou J, Fan J. Multiple carcinogenesis contributes to the heterogeneity of HCC. Nature Reviews. Gastroenterology & Hepatology. 12: 13. PMID 25421581 DOI: 10.1038/Nrgastro.2014.6-C1 |
0.391 |
|
| 2015 |
Fu XT, Dai Z, Song K, Zhang ZJ, Zhou ZJ, Zhou SL, Zhao YM, Xiao YS, Sun QM, Ding ZB, Fan J. Macrophage-secreted IL-8 induces epithelial-mesenchymal transition in hepatocellular carcinoma cells by activating the JAK2/STAT3/Snail pathway. International Journal of Oncology. 46: 587-96. PMID 25405790 DOI: 10.3892/ijo.2014.2761 |
0.372 |
|
| 2015 |
Liu WR, Tian MX, Jin L, Yang LX, Ding ZB, Shen YH, Peng YF, Zhou J, Qiu SJ, Dai Z, Fan J, Shi YH. High levels of hepatitis B surface antigen are associated with poorer survival and early recurrence of hepatocellular carcinoma in patients with low hepatitis B viral loads. Annals of Surgical Oncology. 22: 843-50. PMID 25269529 DOI: 10.1245/S10434-014-4043-5 |
0.372 |
|
| 2015 |
Shi JY, Yang LX, Wang ZC, Wang LY, Zhou J, Wang XY, Shi GM, Ding ZB, Ke AW, Dai Z, Qiu SJ, Tang QQ, Gao Q, Fan J. CC chemokine receptor-like 1 functions as a tumour suppressor by impairing CCR7-related chemotaxis in hepatocellular carcinoma. The Journal of Pathology. 235: 546-58. PMID 25255875 DOI: 10.1002/Path.4450 |
0.401 |
|
| 2014 |
Ni XC, Yi Y, Fu YP, He HW, Cai XY, Wang JX, Zhou J, Fan J, Qiu SJ. Serum amyloid A is a novel prognostic biomarker in hepatocellular carcinoma. Asian Pacific Journal of Cancer Prevention : Apjcp. 15: 10713-8. PMID 25605163 DOI: 10.7314/APJCP.2014.15.24.10713 |
0.383 |
|
| 2014 |
Duan M, Wang ZC, Wang XY, Shi JY, Yang LX, Ding ZB, Gao Q, Zhou J, Fan J. TREM-1, an Inflammatory Modulator, is Expressed in Hepatocellular Carcinoma Cells and Significantly Promotes Tumor Progression. Annals of Surgical Oncology. PMID 25465376 DOI: 10.1245/S10434-014-4191-7 |
0.404 |
|
| 2014 |
Zhou LY, Zeng ZC, Fan J, Chen B, Rao SX, He J, Yang P, Hou JZ, Wu ZF, Zhang JY, Hu Y. Radiotherapy treatment of adrenal gland metastases from hepatocellular carcinoma: clinical features and prognostic factors. Bmc Cancer. 14: 878. PMID 25421498 DOI: 10.1186/1471-2407-14-878 |
0.392 |
|
| 2014 |
Wang W, Cheng J, Qin JJ, Voruganti S, Nag S, Fan J, Gao Q, Zhang R. RYBP expression is associated with better survival of patients with hepatocellular carcinoma (HCC) and responsiveness to chemotherapy of HCC cells in vitro and in vivo. Oncotarget. 5: 11604-19. PMID 25344099 DOI: 10.18632/ONCOTARGET.2598 |
0.441 |
|
| 2014 |
Hu B, Yang XR, Xu Y, Sun YF, Sun C, Guo W, Zhang X, Wang WM, Qiu SJ, Zhou J, Fan J. Systemic immune-inflammation index predicts prognosis of patients after curative resection for hepatocellular carcinoma. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 20: 6212-22. PMID 25271081 DOI: 10.1158/1078-0432.Ccr-14-0442 |
0.365 |
|
| 2014 |
Song FN, Duan M, Liu LZ, Wang ZC, Shi JY, Yang LX, Zhou J, Fan J, Gao Q, Wang XY. RANKL promotes migration and invasion of hepatocellular carcinoma cells via NF-κB-mediated epithelial-mesenchymal transition. Plos One. 9: e108507. PMID 25268581 DOI: 10.1371/Journal.Pone.0108507 |
0.409 |
|
| 2014 |
Qin S, Cheng Y, Liang J, Shen L, Bai Y, Li J, Fan J, Liang L, Zhang Y, Wu G, Rau KM, Yang TS, Jian Z, Liang H, Sun Y. Efficacy and safety of the FOLFOX4 regimen versus doxorubicin in Chinese patients with advanced hepatocellular carcinoma: a subgroup analysis of the EACH study. The Oncologist. 19: 1169-78. PMID 25223462 DOI: 10.1634/theoncologist.2014-0190 |
0.351 |
|
| 2014 |
Guo W, Yang XR, Sun YF, Shen MN, Ma XL, Wu J, Zhang CY, Zhou Y, Xu Y, Hu B, Zhang X, Zhou J, Fan J. Clinical significance of EpCAM mRNA-positive circulating tumor cells in hepatocellular carcinoma by an optimized negative enrichment and qRT-PCR-based platform. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 20: 4794-805. PMID 25009297 DOI: 10.1158/1078-0432.CCR-14-0251 |
0.349 |
|
| 2014 |
Li T, Qin LX, Gong X, Zhou J, Sun HC, Wang L, Qiu SJ, Ye QH, Fan J. Clinical characteristics, outcome, and risk factors for early and late intrahepatic recurrence of female patients after curative resection of hepatocellular carcinoma. Surgery. 156: 651-60. PMID 24998159 DOI: 10.1016/J.Surg.2014.04.008 |
0.388 |
|
| 2014 |
Dai Z, Zhou SL, Zhou ZJ, Bai DS, Xu XY, Fu XT, Chen Q, Zhao YM, Zhu K, Yu L, Yang GH, Wang Z, Wu WZ, Zhou J, Fan J. Capn4 contributes to tumour growth and metastasis of hepatocellular carcinoma by activation of the FAK-Src signalling pathways. The Journal of Pathology. 234: 316-28. PMID 24962955 DOI: 10.1002/Path.4395 |
0.407 |
|
| 2014 |
Huang Y, Yang X, Zhao F, Shen Q, Wang Z, Lv X, Hu B, Yu B, Fan J, Qin W. Overexpression of Dickkopf-1 predicts poor prognosis for patients with hepatocellular carcinoma after orthotopic liver transplantation by promoting cancer metastasis and recurrence. Medical Oncology (Northwood, London, England). 31: 966. PMID 24878698 DOI: 10.1007/s12032-014-0966-8 |
0.473 |
|
| 2014 |
Wang JX, Yi Y, Li YW, Cai XY, He HW, Ni XC, Zhou J, Cheng YF, Jin JJ, Fan J, Qiu SJ. Down-regulation of sirtuin 3 is associated with poor prognosis in hepatocellular carcinoma after resection. Bmc Cancer. 14: 297. PMID 24774224 DOI: 10.1186/1471-2407-14-297 |
0.368 |
|
| 2014 |
Liu WR, Tian MX, Jin L, Yang LX, Ding ZB, Shen YH, Peng YF, Zhou J, Qiu SJ, Dai Z, Fan J, Shi YH. High expression of 5-hydroxymethylcytosine and isocitrate dehydrogenase 2 is associated with favorable prognosis after curative resection of hepatocellular carcinoma. Journal of Experimental & Clinical Cancer Research : Cr. 33: 32. PMID 24716838 DOI: 10.1186/1756-9966-33-32 |
0.403 |
|
| 2014 |
Yang B, Tan Y, Sun H, Fan J, Tang Z, Ji Y. Higher intratumor than peritumor expression of DUSP6/MKP-3 is associated with recurrence after curative resection of hepatocellular carcinoma. Chinese Medical Journal. 127: 1211-7. PMID 24709168 |
0.388 |
|
| 2014 |
Zhou ZJ, Dai Z, Zhou SL, Hu ZQ, Chen Q, Zhao YM, Shi YH, Gao Q, Wu WZ, Qiu SJ, Zhou J, Fan J. HNRNPAB induces epithelial-mesenchymal transition and promotes metastasis of hepatocellular carcinoma by transcriptionally activating SNAIL. Cancer Research. 74: 2750-62. PMID 24638979 DOI: 10.1158/0008-5472.Can-13-2509 |
0.424 |
|
| 2014 |
Cai XY, Wang JX, Yi Y, He HW, Ni XC, Zhou J, Cheng YF, Jin JJ, Fan J, Qiu SJ. Low counts of γδ T cells in peritumoral liver tissue are related to more frequent recurrence in patients with hepatocellular carcinoma after curative resection. Asian Pacific Journal of Cancer Prevention : Apjcp. 15: 775-80. PMID 24568494 DOI: 10.7314/APJCP.2014.15.2.775 |
0.337 |
|
| 2014 |
Jiang JH, Gao Q, Ke AW, Yu Y, Shi GM, Fan J, Zhou J, Huang XW. Prognostic significance of nuclear RNA export factor 3 in hepatocellular carcinoma. Oncology Letters. 7: 641-646. PMID 24520286 DOI: 10.3892/Ol.2014.1809 |
0.421 |
|
| 2014 |
Li YW, Wang JX, Yin X, Qiu SJ, Wu H, Liao R, Yi Y, Xiao YS, Zhou J, Zhang BH, Fan J. Decreased expression of GATA2 promoted proliferation, migration and invasion of HepG2 in vitro and correlated with poor prognosis of hepatocellular carcinoma. Plos One. 9: e87505. PMID 24498120 DOI: 10.1371/Journal.Pone.0087505 |
0.33 |
|
| 2014 |
Jiang JH, Liu YF, Ke AW, Gu FM, Yu Y, Dai Z, Gao Q, Shi GM, Liao BY, Xie YH, Fan J, Huang XW, Zhou J. Clinical significance of the ubiquitin ligase UBE3C in hepatocellular carcinoma revealed by exome sequencing. Hepatology (Baltimore, Md.). 59: 2216-27. PMID 24425307 DOI: 10.1002/Hep.27012 |
0.43 |
|
| 2014 |
Shen YH, Chen S, Peng YF, Shi YH, Huang XW, Yang GH, Ding ZB, Yi Y, Zhou J, Qiu SJ, Fan J, Ren N. Quantitative assessment of the effect of glutathione S-transferase genes GSTM1 and GSTT1 on hepatocellular carcinoma risk. Tumour Biology : the Journal of the International Society For Oncodevelopmental Biology and Medicine. 35: 4007-15. PMID 24399650 DOI: 10.1007/S13277-013-1524-2 |
0.325 |
|
| 2014 |
Hou J, Zhou Y, Zheng Y, Fan J, Zhou W, Ng IO, Sun H, Qin L, Qiu S, Lee JM, Lo CM, Man K, Yang Y, Yang Y, Yang Y, et al. Hepatic RIG-I predicts survival and interferon-α therapeutic response in hepatocellular carcinoma. Cancer Cell. 25: 49-63. PMID 24360797 DOI: 10.1016/J.Ccr.2013.11.011 |
0.401 |
|
| 2014 |
Tang JH, Yan FH, Zhou ML, Xu PJ, Zhou J, Fan J. Evaluation of computer-assisted quantitative volumetric analysis for pre-operative resectability assessment of huge hepatocellular carcinoma. Asian Pacific Journal of Cancer Prevention : Apjcp. 14: 3045-50. PMID 23803077 DOI: 10.7314/apjcp.2013.14.5.3045 |
0.381 |
|
| 2014 |
Wu X, Chen H, Gao Q, Bai J, Wang X, Zhou J, Qiu S, Xu Y, Shi Y, Wang X, Zhou J, Fan J. Downregulation of JWA promotes tumor invasion and predicts poor prognosis in human hepatocellular carcinoma. Molecular Carcinogenesis. 53: 325-36. PMID 23169062 DOI: 10.1002/Mc.21981 |
0.447 |
|
| 2013 |
Jiang JH, Gao Q, Shen XZ, Yu Y, Gu FM, Yan J, Pan JF, Jin F, Fan J, Zhou J, Huang XW. An X-chromosomal association study identifies a susceptibility locus at Xq22.1 for hepatitis B virus-related hepatocellular carcinoma. Clinics and Research in Hepatology and Gastroenterology. 37: 586-95. PMID 24209690 DOI: 10.1016/J.Clinre.2013.09.002 |
0.347 |
|
| 2013 |
Peng YF, Shi YH, Ding ZB, Ke AW, Gu CY, Hui B, Zhou J, Qiu SJ, Dai Z, Fan J. Autophagy inhibition suppresses pulmonary metastasis of HCC in mice via impairing anoikis resistance and colonization of HCC cells. Autophagy. 9: 2056-68. PMID 24157892 DOI: 10.4161/Auto.26398 |
0.389 |
|
| 2013 |
Huang XY, Huang ZL, Xu YH, Huang XY, Zhou J, Ye SL, Fan J, Tang ZY, Zheng Q. [Establishment of a high metastatic potential human hepatocellular carcinoma orthotopic transplantation model with palliative liver resection in nude mice]. Zhonghua Gan Zang Bing Za Zhi = Zhonghua Ganzangbing Zazhi = Chinese Journal of Hepatology. 21: 604-8. PMID 24119741 DOI: 10.3760/cma.j.issn.1007-3418.2013.08.010 |
0.344 |
|
| 2013 |
Peng YF, Shi YH, Shen YH, Ding ZB, Ke AW, Zhou J, Qiu SJ, Fan J. Promoting colonization in metastatic HCC cells by modulation of autophagy. Plos One. 8: e74407. PMID 24058558 DOI: 10.1371/Journal.Pone.0074407 |
0.417 |
|
| 2013 |
Shi JY, Gao Q, Wang ZC, Zhou J, Wang XY, Min ZH, Shi YH, Shi GM, Ding ZB, Ke AW, Dai Z, Qiu SJ, Song K, Fan J. Margin-infiltrating CD20(+) B cells display an atypical memory phenotype and correlate with favorable prognosis in hepatocellular carcinoma. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 19: 5994-6005. PMID 24056784 DOI: 10.1158/1078-0432.Ccr-12-3497 |
0.32 |
|
| 2013 |
Qin S, Bai Y, Lim HY, Thongprasert S, Chao Y, Fan J, Yang TS, Bhudhisawasdi V, Kang WK, Zhou Y, Lee JH, Sun Y. Randomized, multicenter, open-label study of oxaliplatin plus fluorouracil/leucovorin versus doxorubicin as palliative chemotherapy in patients with advanced hepatocellular carcinoma from Asia. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 31: 3501-8. PMID 23980077 DOI: 10.1200/JCO.2012.44.5643 |
0.384 |
|
| 2013 |
Xiao YS, Gao Q, Xu XN, Li YW, Ju MJ, Cai MY, Dai CX, Hu J, Qiu SJ, Zhou J, Fan J. Combination of intratumoral invariant natural killer T cells and interferon-gamma is associated with prognosis of hepatocellular carcinoma after curative resection. Plos One. 8: e70345. PMID 23940564 DOI: 10.1371/Journal.Pone.0070345 |
0.389 |
|
| 2013 |
Liu Y, Zhao YM, Akers W, Tang ZY, Fan J, Sun HC, Ye QH, Wang L, Achilefu S. First in-human intraoperative imaging of HCC using the fluorescence goggle system and transarterial delivery of near-infrared fluorescent imaging agent: a pilot study. Translational Research : the Journal of Laboratory and Clinical Medicine. 162: 324-31. PMID 23747795 DOI: 10.1016/J.Trsl.2013.05.002 |
0.317 |
|
| 2013 |
Wang ZC, Gao Q, Shi JY, Yang LX, Zhou J, Wang XY, Shi YH, Ke AW, Shi GM, Ding ZB, Dai Z, Qiu SJ, Fan J. Genetic polymorphism of the kinesin-like protein KIF1B gene and the risk of hepatocellular carcinoma. Plos One. 8: e62571. PMID 23634229 DOI: 10.1371/Journal.Pone.0062571 |
0.312 |
|
| 2013 |
Liao R, Wu H, Yi Y, Wang JX, Cai XY, He HW, Cheng YF, Zhou J, Fan J, Sun J, Qiu SJ. Clinical significance and gene expression study of human hepatic stellate cells in HBV related-hepatocellular carcinoma. Journal of Experimental & Clinical Cancer Research : Cr. 32: 22. PMID 23601182 DOI: 10.1186/1756-9966-32-22 |
0.397 |
|
| 2013 |
Wu H, Chen P, Liao R, Li YW, Yi Y, Wang JX, Cai XY, He HW, Jin JJ, Cheng YF, Fan J, Sun J, Qiu SJ. Intratumoral regulatory T cells with higher prevalence and more suppressive activity in hepatocellular carcinoma patients. Journal of Gastroenterology and Hepatology. 28: 1555-64. PMID 23517245 DOI: 10.1111/jgh.12202 |
0.313 |
|
| 2013 |
Zhai XF, Chen Z, Li B, Shen F, Fan J, Zhou WP, Yang YK, Xu J, Qin X, Li LQ, Ling CQ. Traditional herbal medicine in preventing recurrence after resection of small hepatocellular carcinoma: a multicenter randomized controlled trial. Journal of Integrative Medicine. 11: 90-100. PMID 23506690 DOI: 10.3736/jintegrmed2013021 |
0.324 |
|
| 2013 |
Tao ZH, Wan JL, Zeng LY, Xie L, Sun HC, Qin LX, Wang L, Zhou J, Ren ZG, Li YX, Fan J, Wu WZ. miR-612 suppresses the invasive-metastatic cascade in hepatocellular carcinoma. The Journal of Experimental Medicine. 210: 789-803. PMID 23478189 DOI: 10.1084/Jem.20120153 |
0.316 |
|
| 2013 |
Peng YF, Shi YH, Ding ZB, Zhou J, Qiu SJ, Hui B, Gu CY, Yang H, Liu WR, Fan J. α-Fetoprotein promoter-driven Cre/LoxP-switched RNA interference for hepatocellular carcinoma tissue-specific target therapy. Plos One. 8: e53072. PMID 23468839 DOI: 10.1371/Journal.Pone.0053072 |
0.367 |
|
| 2013 |
Huang C, Wang Y, Liu S, Ding G, Liu W, Zhou J, Kuang M, Ji Y, Kondo T, Fan J. Quantitative proteomic analysis identified paraoxonase 1 as a novel serum biomarker for microvascular invasion in hepatocellular carcinoma. Journal of Proteome Research. 12: 1838-46. PMID 23442176 DOI: 10.1021/Pr3011815 |
0.399 |
|
| 2013 |
Yan J, Tan C, Gu F, Jiang J, Xu M, Huang X, Dai Z, Wang Z, Fan J, Zhou J. Sorafenib delays recurrence and metastasis after liver transplantation in a rat model of hepatocellular carcinoma with high expression of phosphorylated extracellular signal-regulated kinase Liver Transplantation. 19: 507-520. PMID 23408515 DOI: 10.1002/Lt.23619 |
0.379 |
|
| 2013 |
Budhu A, Roessler S, Zhao X, Yu Z, Forgues M, Ji J, Karoly E, Qin LX, Ye QH, Jia HL, Fan J, Sun HC, Tang ZY, Wang XW. Integrated metabolite and gene expression profiles identify lipid biomarkers associated with progression of hepatocellular carcinoma and patient outcomes. Gastroenterology. 144: 1066-1075.e1. PMID 23376425 DOI: 10.1053/J.Gastro.2013.01.054 |
0.351 |
|
| 2013 |
Zhang C, Bai DS, Huang XY, Shi GM, Ke AW, Yang LX, Yang XR, Zhou J, Fan J. Prognostic significance of Capn4 overexpression in intrahepatic cholangiocarcinoma. Plos One. 8: e54619. PMID 23349941 DOI: 10.1371/journal.pone.0054619 |
0.361 |
|
| 2013 |
Huang XY, Ke AW, Shi GM, Zhang X, Zhang C, Shi YH, Wang XY, Ding ZB, Xiao YS, Yan J, Qiu SJ, Fan J, Zhou J. αB-crystallin complexes with 14-3-3ζ to induce epithelial-mesenchymal transition and resistance to sorafenib in hepatocellular carcinoma. Hepatology (Baltimore, Md.). 57: 2235-47. PMID 23316005 DOI: 10.1002/hep.26255 |
0.401 |
|
| 2013 |
Gao YB, Xiang ZL, Zhou LY, Wu ZF, Fan J, Zeng HY, Zeng ZC. Enhanced production of CTGF and IL-11 from highly metastatic hepatoma cells under hypoxic conditions: an implication of hepatocellular carcinoma metastasis to bone. Journal of Cancer Research and Clinical Oncology. 139: 669-79. PMID 23307318 DOI: 10.1007/s00432-012-1370-4 |
0.37 |
|
| 2013 |
Jiang DK, Sun J, Cao G, Liu Y, Lin D, Gao YZ, Ren WH, Long XD, Zhang H, Ma XP, Wang Z, Jiang W, Chen TY, Gao Y, Sun LD, ... ... Fan J, et al. Genetic variants in STAT4 and HLA-DQ genes confer risk of hepatitis B virus-related hepatocellular carcinoma. Nature Genetics. 45: 72-5. PMID 23242368 DOI: 10.1038/Ng.2483 |
0.349 |
|
| 2013 |
Sun HX, Xu Y, Yang XR, Wang WM, Bai H, Shi RY, Nayar SK, Devbhandari RP, He YZ, Zhu QF, Sun YF, Hu B, Khan M, Anders RA, Fan J. Hypoxia inducible factor 2 alpha inhibits hepatocellular carcinoma growth through the transcription factor dimerization partner 3/ E2F transcription factor 1-dependent apoptotic pathway. Hepatology (Baltimore, Md.). 57: 1088-97. PMID 23212661 DOI: 10.1002/hep.26188 |
0.321 |
|
| 2013 |
Sun YF, Xu Y, Yang XR, Guo W, Zhang X, Qiu SJ, Shi RY, Hu B, Zhou J, Fan J. Circulating stem cell-like epithelial cell adhesion molecule-positive tumor cells indicate poor prognosis of hepatocellular carcinoma after curative resection. Hepatology (Baltimore, Md.). 57: 1458-68. PMID 23175471 DOI: 10.1002/hep.26151 |
0.366 |
|
| 2013 |
Zhang X, Yang XR, Huang XW, Wang WM, Shi RY, Xu Y, Wang Z, Qiu SJ, Fan J, Zhou J. Sorafenib in treatment of patients with advanced hepatocellular carcinoma: a systematic review. Hepatobiliary & Pancreatic Diseases International : Hbpd Int. 11: 458-66. PMID 23060390 DOI: 10.1016/S1499-3872(12)60209-4 |
0.394 |
|
| 2013 |
Yi Y, Wu H, Gao Q, He HW, Li YW, Cai XY, Wang JX, Zhou J, Cheng YF, Jin JJ, Fan J, Qiu SJ. Interferon regulatory factor (IRF)-1 and IRF-2 are associated with prognosis and tumor invasion in HCC. Annals of Surgical Oncology. 20: 267-76. PMID 22805863 DOI: 10.1245/s10434-012-2487-z |
0.392 |
|
| 2013 |
Li T, Qin LX, Gong X, Zhou J, Sun HC, Qiu SJ, Ye QH, Wang L, Fan J. Hepatitis B virus surface antigen-negative and hepatitis C virus antibody-negative hepatocellular carcinoma: clinical characteristics, outcome, and risk factors for early and late intrahepatic recurrence after resection. Cancer. 119: 126-35. PMID 22736338 DOI: 10.1002/Cncr.27697 |
0.329 |
|
| 2013 |
Zhou SL, Dai Z, Zhou ZJ, Wang XY, Yang GH, Wang Z, Huang XW, Fan J, Zhou J. Overexpression of CXCL5 mediates neutrophil infiltration and indicates poor prognosis for hepatocellular carcinoma. Hepatology (Baltimore, Md.). 56: 2242-54. PMID 22711685 DOI: 10.1002/Hep.25907 |
0.448 |
|
| 2013 |
Xu Y, Hu B, Anders R, Maitra A, Fan J. Use of nanocurcumin to inhibit proliferation and metastases of hepatocellular carcinoma via NF-κB mediated matrix metalloproteinase-9 downregulation. Journal of Clinical Oncology. 31: e22103-e22103. DOI: 10.1200/JCO.2013.31.15_SUPPL.E22103 |
0.388 |
|
| 2012 |
Lin S, Zhu Q, Xu Y, Liu H, Zhang J, Xu J, Wang H, Sang Q, Xing Q, Fan J. The role of the TOB1 gene in growth suppression of hepatocellular carcinoma. Oncology Letters. 4: 981-987. PMID 23162636 DOI: 10.3892/ol.2012.864 |
0.388 |
|
| 2012 |
Wang JL, Tao ZH, Wu WZ, Tang J, Sun HC, Wang L, Ren ZG, Fan J. [A nude mouse model of hepatocellular carcinoma single cell-derived organ site-specific metastasis]. Zhonghua Gan Zang Bing Za Zhi = Zhonghua Ganzangbing Zazhi = Chinese Journal of Hepatology. 20: 532-6. PMID 23044240 DOI: 10.3760/Cma.J.Issn.1007-3418.2012.07.011 |
0.353 |
|
| 2012 |
Liu WR, Shi YH, Peng YF, Fan J. Epigenetics of hepatocellular carcinoma: a new horizon. Chinese Medical Journal. 125: 2349-60. PMID 22882861 |
0.34 |
|
| 2012 |
Zhou J, Shi YH, Fan J. Circulating cell-free nucleic acids: promising biomarkers of hepatocellular carcinoma. Seminars in Oncology. 39: 440-8. PMID 22846861 DOI: 10.1053/J.Seminoncol.2012.05.013 |
0.378 |
|
| 2012 |
Zhou ZJ, Dai Z, Zhou SL, Fu XT, Zhao YM, Shi YH, Zhou J, Fan J. Overexpression of HnRNP A1 promotes tumor invasion through regulating CD44v6 and indicates poor prognosis for hepatocellular carcinoma. International Journal of Cancer. 132: 1080-9. PMID 22821376 DOI: 10.1002/Ijc.27742 |
0.375 |
|
| 2012 |
Zhang L, Sun H, Zhao F, Lu P, Ge C, Li H, Hou H, Yan M, Chen T, Jiang G, Xie H, Cui Y, Huang X, Fan J, Yao M, et al. BMP4 administration induces differentiation of CD133+ hepatic cancer stem cells, blocking their contributions to hepatocellular carcinoma. Cancer Research. 72: 4276-85. PMID 22773665 DOI: 10.1158/0008-5472.CAN-12-1013 |
0.307 |
|
| 2012 |
Shen Q, Fan J, Yang XR, Tan Y, Zhao W, Xu Y, Wang N, Niu Y, Wu Z, Zhou J, Qiu SJ, Shi YH, Yu B, Tang N, Chu W, et al. Serum DKK1 as a protein biomarker for the diagnosis of hepatocellular carcinoma: a large-scale, multicentre study. The Lancet. Oncology. 13: 817-26. PMID 22738799 DOI: 10.1016/S1470-2045(12)70233-4 |
0.381 |
|
| 2012 |
Sun TW, Gao Q, Qiu SJ, Zhou J, Wang XY, Yi Y, Shi JY, Xu YF, Shi YH, Song K, Xiao YS, Fan J. B7-H3 is expressed in human hepatocellular carcinoma and is associated with tumor aggressiveness and postoperative recurrence. Cancer Immunology, Immunotherapy : Cii. 61: 2171-82. PMID 22729558 DOI: 10.1007/S00262-012-1278-5 |
0.312 |
|
| 2012 |
Gao Q, Zhao YJ, Wang XY, Qiu SJ, Shi YH, Sun J, Yi Y, Shi JY, Shi GM, Ding ZB, Xiao YS, Zhao ZH, Zhou J, He XH, Fan J. CXCR6 upregulation contributes to a proinflammatory tumor microenvironment that drives metastasis and poor patient outcomes in hepatocellular carcinoma. Cancer Research. 72: 3546-56. PMID 22710437 DOI: 10.1158/0008-5472.Can-11-4032 |
0.434 |
|
| 2012 |
Gao Q, Shi Y, Wang X, Zhou J, Qiu S, Fan J. Translational medicine in hepatocellular carcinoma Frontiers of Medicine in China. 6: 122-133. PMID 22573220 DOI: 10.1007/S11684-012-0193-7 |
0.42 |
|
| 2012 |
Wang CJ, Xiao CW, You TG, Zheng YX, Gao W, Zhou ZQ, Chen J, Xue XB, Fan J, Zhang H. Interferon-α enhances antitumor activities of oncolytic adenovirus-mediated IL-24 expression in hepatocellular carcinoma. Molecular Cancer. 11: 31. PMID 22569271 DOI: 10.1186/1476-4598-11-31 |
0.328 |
|
| 2012 |
Huang C, Ding G, Gu C, Zhou J, Kuang M, Ji Y, He Y, Kondo T, Fan J. Decreased selenium-binding protein 1 enhances glutathione peroxidase 1 activity and downregulates HIF-1α to promote hepatocellular carcinoma invasiveness. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 18: 3042-53. PMID 22512980 DOI: 10.1158/1078-0432.Ccr-12-0183 |
0.369 |
|
| 2012 |
Song K, Gao Q, Zhou J, Qiu SJ, Huang XW, Wang XY, Fan J. Prognostic significance and clinical relevance of Sprouty 2 protein expression in human hepatocellular carcinoma. Hepatobiliary & Pancreatic Diseases International : Hbpd Int. 11: 177-84. PMID 22484587 DOI: 10.1016/S1499-3872(12)60145-3 |
0.392 |
|
| 2012 |
Yin X, Li YW, Zhang BH, Ren ZG, Qiu SJ, Yi Y, Fan J. Coexpression of stemness factors Oct4 and Nanog predict liver resection. Annals of Surgical Oncology. 19: 2877-87. PMID 22461131 DOI: 10.1245/s10434-012-2314-6 |
0.301 |
|
| 2012 |
Yin X, Zhang BH, Qiu SJ, Ren ZG, Zhou J, Chen XH, Zhou Y, Fan J. Combined hepatocellular carcinoma and cholangiocarcinoma: clinical features, treatment modalities, and prognosis. Annals of Surgical Oncology. 19: 2869-76. PMID 22451237 DOI: 10.1245/s10434-012-2328-0 |
0.321 |
|
| 2012 |
Wu H, Chen P, Liao R, Li YW, Yi Y, Wang JX, Sun TW, Zhou J, Shi YH, Yang XR, Jin JJ, Cheng YF, Fan J, Qiu SJ. Overexpression of galectin-1 is associated with poor prognosis in human hepatocellular carcinoma following resection. Journal of Gastroenterology and Hepatology. 27: 1312-9. PMID 22432916 DOI: 10.1111/J.1440-1746.2012.07130.X |
0.425 |
|
| 2012 |
Li QL, Gu FM, Wang Z, Jiang JH, Yao LQ, Tan CJ, Huang XY, Ke AW, Dai Z, Fan J, Zhou J. Activation of PI3K/AKT and MAPK pathway through a PDGFRβ-dependent feedback loop is involved in rapamycin resistance in hepatocellular carcinoma. Plos One. 7: e33379. PMID 22428038 DOI: 10.1371/journal.pone.0033379 |
0.328 |
|
| 2012 |
Liao R, Sun TW, Yi Y, Wu H, Li YW, Wang JX, Zhou J, Shi YH, Cheng YF, Qiu SJ, Fan J. Expression of TREM-1 in hepatic stellate cells and prognostic value in hepatitis B-related hepatocellular carcinoma. Cancer Science. 103: 984-92. PMID 22417086 DOI: 10.1111/J.1349-7006.2012.02273.X |
0.443 |
|
| 2012 |
Hou JZ, Zeng ZC, Zhang JY, Fan J, Zhou J, Zeng MS. Influence of tumor thrombus location on the outcome of external-beam radiation therapy in advanced hepatocellular carcinoma with macrovascular invasion. International Journal of Radiation Oncology, Biology, Physics. 84: 362-8. PMID 22381903 DOI: 10.1016/J.Ijrobp.2011.12.024 |
0.338 |
|
| 2012 |
Gu FM, Li QL, Gao Q, Jiang JH, Huang XY, Pan JF, Fan J, Zhou J. Sorafenib inhibits growth and metastasis of hepatocellular carcinoma by blocking STAT3. World Journal of Gastroenterology. 17: 3922-32. PMID 22025881 DOI: 10.3748/wjg.v17.i34.3922 |
0.382 |
|
| 2012 |
Zhao YM, Zhou JM, Wang LR, He HW, Wang XL, Tao ZH, Sun HC, Wu WZ, Fan J, Tang ZY, Wang L. HIWI is associated with prognosis in patients with hepatocellular carcinoma after curative resection. Cancer. 118: 2708-17. PMID 21989785 DOI: 10.1002/Cncr.26524 |
0.384 |
|
| 2012 |
Xu Y, Chenna V, Hu C, Sun HX, Khan M, Bai H, Yang XR, Zhu QF, Sun YF, Maitra A, Fan J, Anders RA. Polymeric nanoparticle-encapsulated hedgehog pathway inhibitor HPI-1 (NanoHHI) inhibits systemic metastases in an orthotopic model of human hepatocellular carcinoma. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 18: 1291-302. PMID 21868763 DOI: 10.1158/1078-0432.CCR-11-0950 |
0.364 |
|
| 2012 |
Liang Y, Li WW, Yang BW, Tao ZH, Sun HC, Wang L, Xia JL, Qin LX, Tang ZY, Fan J, Wu WZ. Aryl hydrocarbon receptor nuclear translocator is associated with tumor growth and progression of hepatocellular carcinoma. International Journal of Cancer. Journal International Du Cancer. 130: 1745-54. PMID 21544813 DOI: 10.1002/Ijc.26166 |
0.413 |
|
| 2011 |
Yu L, Dai Z, Wang Z, Fan J, Zhou J. Prognostic indicators for tumor recurrence after liver transplantation in hepatocellular carcinoma and related molecular targeted therapy. Oncology. 116-22. PMID 22212945 DOI: 10.1159/000333273 |
0.428 |
|
| 2011 |
He J, Zeng ZC, Fan J, Zhou J, Sun J, Chen B, Yang P, Wang BL, Zhang BH, Zhang JY. Clinical features and prognostic factors in patients with bone metastases from hepatocellular carcinoma after liver transplantation. Bmc Cancer. 11: 492. PMID 22107882 DOI: 10.1186/1471-2407-11-492 |
0.339 |
|
| 2011 |
Zhou J, Yu L, Gao X, Hu J, Wang J, Dai Z, Wang JF, Zhang Z, Lu S, Huang X, Wang Z, Qiu S, Wang X, Yang G, Sun H, ... ... Fan J, et al. Plasma microRNA panel to diagnose hepatitis B virus-related hepatocellular carcinoma. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 29: 4781-8. PMID 22105822 DOI: 10.1200/Jco.2011.38.2697 |
0.308 |
|
| 2011 |
Ai J, Tang Q, Wu Y, Xu Y, Feng T, Zhou R, Chen Y, Gao X, Zhu Q, Yue X, Pan Q, Xu S, Li J, Huang M, Daugherty-Holtrop J, ... ... Fan J, et al. The role of polymeric immunoglobulin receptor in inflammation-induced tumor metastasis of human hepatocellular carcinoma. Journal of the National Cancer Institute. 103: 1696-712. PMID 22025622 DOI: 10.1093/Jnci/Djr360 |
0.355 |
|
| 2011 |
Hu J, Wang Z, Fan J, Dai Z, He YF, Qiu SJ, Huang XW, Sun J, Xiao YS, Song K, Shi YH, Sun QM, Yang XR, Shi GM, Yu L, et al. Genetic variations in plasma circulating DNA of HBV-related hepatocellular carcinoma patients predict recurrence after liver transplantation. Plos One. 6: e26003. PMID 21998744 DOI: 10.1371/Journal.Pone.0026003 |
0.364 |
|
| 2011 |
Zhu K, Dai Z, Pan Q, Wang Z, Yang GH, Yu L, Ding ZB, Shi GM, Ke AW, Yang XR, Tao ZH, Zhao YM, Qin Y, Zeng HY, Tang ZY, ... Fan J, et al. Metadherin promotes hepatocellular carcinoma metastasis through induction of epithelial-mesenchymal transition. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 17: 7294-302. PMID 21976539 DOI: 10.1158/1078-0432.Ccr-11-1327 |
0.415 |
|
| 2011 |
Xiang ZL, Zeng ZC, Fan J, Wu WZ, He J, Zeng HY, Tang ZY. A clinicopathological model to predict bone metastasis in hepatocellular carcinoma. Journal of Cancer Research and Clinical Oncology. 137: 1791-7. PMID 21915751 DOI: 10.1007/s00432-011-1060-7 |
0.331 |
|
| 2011 |
Ding ZB, Hui B, Shi YH, Zhou J, Peng YF, Gu CY, Yang H, Shi GM, Ke AW, Wang XY, Song K, Dai Z, Shen YH, Fan J. Autophagy activation in hepatocellular carcinoma contributes to the tolerance of oxaliplatin via reactive oxygen species modulation. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 17: 6229-38. PMID 21825039 DOI: 10.1158/1078-0432.Ccr-11-0816 |
0.409 |
|
| 2011 |
Wang WM, Xu Y, Yang XR, Wang YH, Sun HX, Fan J. Prognostic role of diabetes mellitus in hepatocellular carcinoma patients after curative treatments: a meta-analysis. Hepatobiliary & Pancreatic Diseases International : Hbpd Int. 10: 346-55. PMID 21813381 DOI: 10.1016/S1499-3872(11)60059-3 |
0.364 |
|
| 2011 |
Gao Q, Zhou J, Wang XY, Qiu SJ, Song K, Huang XW, Sun J, Shi YH, Li BZ, Xiao YS, Fan J. Infiltrating memory/senescent T cell ratio predicts extrahepatic metastasis of hepatocellular carcinoma. Annals of Surgical Oncology. 19: 455-66. PMID 21792513 DOI: 10.1245/S10434-011-1864-3 |
0.388 |
|
| 2011 |
Xiang ZL, Zeng ZC, Fan J, Tang ZY, Zeng HY, Gao DM. Gene expression profiling of fixed tissues identified hypoxia-inducible factor-1α, VEGF, and matrix metalloproteinase-2 as biomarkers of lymph node metastasis in hepatocellular carcinoma. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 17: 5463-72. PMID 21712445 DOI: 10.1158/1078-0432.CCR-10-3096 |
0.333 |
|
| 2011 |
Shi YH, Ding ZB, Zhou J, Hui B, Shi GM, Ke AW, Wang XY, Dai Z, Peng YF, Gu CY, Qiu SJ, Fan J. Targeting autophagy enhances sorafenib lethality for hepatocellular carcinoma via ER stress-related apoptosis. Autophagy. 7: 1159-72. PMID 21691147 DOI: 10.4161/Auto.7.10.16818 |
0.347 |
|
| 2011 |
Xiang ZL, Zeng ZC, Tang ZY, Fan J, He J, Zeng HY, Zhu XD. Potential prognostic biomarkers for bone metastasis from hepatocellular carcinoma. The Oncologist. 16: 1028-39. PMID 21665914 DOI: 10.1634/theoncologist.2010-0358 |
0.402 |
|
| 2011 |
Xiang ZL, Zeng ZC, Fan J, Tang ZY, He J, Zeng HY, Chang JY. The expression of HIF-1α in primary hepatocellular carcinoma and its correlation with radiotherapy response and clinical outcome. Molecular Biology Reports. 39: 2021-9. PMID 21647551 DOI: 10.1007/s11033-011-0949-1 |
0.325 |
|
| 2011 |
Gao Q, Wang XY, Qiu SJ, Zhou J, Shi YH, Zhang BH, Fan J. Tumor stroma reaction-related gene signature predicts clinical outcome in human hepatocellular carcinoma. Cancer Science. 102: 1522-31. PMID 21564420 DOI: 10.1111/J.1349-7006.2011.01981.X |
0.387 |
|
| 2011 |
Chen XH, Zhang BH, Xin Y, Ren ZG, Fan J, Qiu SJ, Zhou J. Risk factors for residual tumor after resection of hepatocellular carcinoma. World Journal of Gastroenterology. 17: 1889-94. PMID 21528064 DOI: 10.3748/Wjg.V17.I14.1889 |
0.386 |
|
| 2011 |
Chen T, Xie G, Wang X, Fan J, Qiu Y, Zheng X, Qi X, Cao Y, Su M, Wang X, Xu LX, Yen Y, Liu P, Jia W. Serum and urine metabolite profiling reveals potential biomarkers of human hepatocellular carcinoma. Molecular & Cellular Proteomics : McP. 10: M110.004945. PMID 21518826 DOI: 10.1074/Mcp.M110.004945 |
0.382 |
|
| 2011 |
Xiao CL, Tao ZH, Guo L, Li WW, Wan JL, Sun HC, Wang L, Tang ZY, Fan J, Wu WZ. Isomalto oligosaccharide sulfate inhibits tumor growth and metastasis of hepatocellular carcinoma in nude mice. Bmc Cancer. 11: 150. PMID 21513518 DOI: 10.1186/1471-2407-11-150 |
0.396 |
|
| 2011 |
Ke AW, Shi GM, Zhou J, Huang XY, Shi YH, Ding ZB, Wang XY, Devbhandari RP, Fan J. CD151 amplifies signaling by integrin α6β1 to PI3K and induces the epithelial-mesenchymal transition in HCC cells. Gastroenterology. 140: 1629-41.e15. PMID 21320503 DOI: 10.1053/j.gastro.2011.02.008 |
0.362 |
|
| 2011 |
Zhao Y, Wang X, Wang T, Hu X, Hui X, Yan M, Gao Q, Chen T, Li J, Yao M, Wan D, Gu J, Fan J, He X. Acetylcholinesterase, a key prognostic predictor for hepatocellular carcinoma, suppresses cell growth and induces chemosensitization. Hepatology (Baltimore, Md.). 53: 493-503. PMID 21274871 DOI: 10.1002/hep.24079 |
0.397 |
|
| 2011 |
Li T, Fan J, Qin LX, Zhou J, Sun HC, Qiu SJ, Ye QH, Wang L, Tang ZY. Risk factors, prognosis, and management of early and late intrahepatic recurrence after resection of primary clear cell carcinoma of the liver. Annals of Surgical Oncology. 18: 1955-63. PMID 21240562 DOI: 10.1245/S10434-010-1540-Z |
0.383 |
|
| 2011 |
Zhao YM, Wang L, Dai Z, Wang DD, Hei ZY, Zhang N, Fu XT, Wang XL, Zhang SC, Qin LX, Tang ZY, Zhou J, Fan J. Validity of plasma macrophage migration inhibitory factor for diagnosis and prognosis of hepatocellular carcinoma. International Journal of Cancer. Journal International Du Cancer. 129: 2463-72. PMID 21213214 DOI: 10.1002/Ijc.25918 |
0.339 |
|
| 2011 |
Zhao W, Zhang L, Yin Z, Su W, Ren G, Zhou C, You J, Fan J, Wang X. Activated hepatic stellate cells promote hepatocellular carcinoma development in immunocompetent mice. International Journal of Cancer. 129: 2651-61. PMID 21213212 DOI: 10.1002/ijc.25920 |
0.403 |
|
| 2011 |
Dai Z, Zhou J, Fan J. [Cellular signaling pathways involved in hepatocellular carcinoma occurrence and progression]. Zhonghua Gan Zang Bing Za Zhi = Zhonghua Ganzangbing Zazhi = Chinese Journal of Hepatology. 18: 955-7. PMID 21205491 DOI: 10.3760/Cma.J.Issn.1007-3418.2010.12.022 |
0.389 |
|
| 2011 |
Li YW, Qiu SJ, Fan J, Zhou J, Gao Q, Xiao YS, Xu YF. Intratumoral neutrophils: a poor prognostic factor for hepatocellular carcinoma following resection. Journal of Hepatology. 54: 497-505. PMID 21112656 DOI: 10.1016/j.jhep.2010.07.044 |
0.428 |
|
| 2011 |
Wang DD, Zhao YM, Wang L, Ren G, Wang F, Xia ZG, Wang XL, Zhang T, Pan Q, Dai Z, Chen JP, Dai HY, Zhang W, He HW, Zhou JM, ... ... Fan J, et al. Preoperative serum retinol-binding protein 4 is associated with the prognosis of patients with hepatocellular carcinoma after curative resection. Journal of Cancer Research and Clinical Oncology. 137: 651-8. PMID 20549233 DOI: 10.1007/S00432-010-0927-3 |
0.396 |
|
| 2011 |
Xu HX, Zhu XD, Zhuang PY, Zhang JB, Zhang W, Kong LQ, Wang WQ, Liang Y, Wu WZ, Wang L, Fan J, Tang ZY, Sun HC. Expression and prognostic significance of placental growth factor in hepatocellular carcinoma and peritumoral liver tissue. International Journal of Cancer. Journal International Du Cancer. 128: 1559-69. PMID 20521248 DOI: 10.1002/Ijc.25492 |
0.383 |
|
| 2011 |
Fan J, Wang Z. [Hepatectomy for hepatocellular carcinoma]. Zhonghua Wai Ke Za Zhi [Chinese Journal of Surgery]. 48: 167-8. PMID 20388411 |
0.392 |
|
| 2010 |
Chen XH, Zhang BH, Qiu SJ, Fan J, Ren ZG, Xia JL, Wang YH, Gan YH, Yin X, Ye SL. [Effect of postoperative adjuvant transarterial chemoembolization on late recurrence of hepatocellular carcinoma after radical resection]. Zhonghua Gan Zang Bing Za Zhi = Zhonghua Ganzangbing Zazhi = Chinese Journal of Hepatology. 18: 599-603. PMID 20825715 DOI: 10.3760/cma.j.issn.1007-3418.2010.08.012 |
0.387 |
|
| 2010 |
Xu YF, Yi Y, Qiu SJ, Gao Q, Li YW, Dai CX, Cai MY, Ju MJ, Zhou J, Zhang BH, Fan J. PEBP1 downregulation is associated to poor prognosis in HCC related to hepatitis B infection. Journal of Hepatology. 53: 872-9. PMID 20739083 DOI: 10.1016/J.Jhep.2010.05.019 |
0.412 |
|
| 2010 |
Li JC, Yang XR, Sun HX, Xu Y, Zhou J, Qiu SJ, Ke AW, Cui YH, Wang ZJ, Wang WM, Liu KD, Fan J. Up-regulation of Krüppel-like factor 8 promotes tumor invasion and indicates poor prognosis for hepatocellular carcinoma. Gastroenterology. 139: 2146-2157.e12. PMID 20728449 DOI: 10.1053/j.gastro.2010.08.004 |
0.388 |
|
| 2010 |
Chen XH, Zhang BH, Yin X, Qiu SJ, Fan J, Ren ZG, Xia JL, Wang YH, Ye SL, Gan YH. [Effect of postoperative adjuvant transarterial chemoembolization upon early recurrence after radical resection of hepatocellular carcinoma]. Zhonghua Yi Xue Za Zhi. 90: 826-9. PMID 20450622 |
0.385 |
|
| 2010 |
Yang XR, Xu Y, Yu B, Zhou J, Qiu SJ, Shi GM, Zhang BH, Wu WZ, Shi YH, Wu B, Yang GH, Ji Y, Fan J. High expression levels of putative hepatic stem/progenitor cell biomarkers related to tumour angiogenesis and poor prognosis of hepatocellular carcinoma Gut. 59: 953-962. PMID 20442200 DOI: 10.1136/Gut.2008.176271 |
0.388 |
|
| 2010 |
Yuan Z, Zheng Q, Fan J, Ai KX, Chen J, Huang XY. Expression and prognostic significance of focal adhesion kinase in hepatocellular carcinoma. Journal of Cancer Research and Clinical Oncology. 136: 1489-96. PMID 20151150 DOI: 10.1007/s00432-010-0806-y |
0.368 |
|
| 2010 |
Zhou J, Wang Z, Qiu SJ, Huang XW, Sun J, Gu W, Fan J. Surgical treatment for early hepatocellular carcinoma: comparison of resection and liver transplantation. Journal of Cancer Research and Clinical Oncology. 136: 1453-60. PMID 20148264 DOI: 10.1007/S00432-010-0802-2 |
0.375 |
|
| 2010 |
Feng R, Wang SY, Shi YH, Fan J, Yin XM. Delphinidin induces necrosis in hepatocellular carcinoma cells in the presence of 3-methyladenine, an autophagy inhibitor. Journal of Agricultural and Food Chemistry. 58: 3957-64. PMID 20025272 DOI: 10.1021/jf9025458 |
0.336 |
|
| 2010 |
Wang Z, Zhou J, Fan J, Qiu SJ, Yu Y, Huang XW, Sun J, Tan CJ, Dai Z. Oxaliplatin induces apoptosis in hepatocellular carcinoma cells and inhibits tumor growth. Expert Opinion On Investigational Drugs. 18: 1595-604. PMID 19780708 DOI: 10.1517/13543780903292626 |
0.38 |
|
| 2010 |
Wang MH, Ji Y, Zeng ZC, Tang ZY, Fan J, Zhou J, Zeng MS, Bi AH, Tan YS. Impact factors for microinvasion in patients with hepatocellular carcinoma: possible application to the definition of clinical tumor volume. International Journal of Radiation Oncology, Biology, Physics. 76: 467-76. PMID 19406586 DOI: 10.1016/J.Ijrobp.2009.01.057 |
0.349 |
|
| 2010 |
Fan J, Wang XY. [Surgical treatment for hepatocellular carcinoma patients with portal vein tumor thrombosis]. Zhonghua Gan Zang Bing Za Zhi = Zhonghua Ganzangbing Zazhi = Chinese Journal of Hepatology. 16: 71-3. PMID 18226354 |
0.361 |
|
| 2010 |
Dai Z, Zhou J, Li XF, Liu YK, Fan J. [An analysis of annexin II related to HCC metastatic ability]. Zhonghua Gan Zang Bing Za Zhi = Zhonghua Ganzangbing Zazhi = Chinese Journal of Hepatology. 15: 563-6. PMID 17711622 |
0.367 |
|
| 2010 |
Fan J, Xu Y. [Indications of liver transplantation for hepatocellular carcinoma patients]. Zhonghua Gan Zang Bing Za Zhi = Zhonghua Ganzangbing Zazhi = Chinese Journal of Hepatology. 14: 536-7. PMID 16867279 |
0.323 |
|
| 2009 |
Xiang Z, Zeng Z, Tang Z, Fan J, Sun H, Wu W, Tan Y. Increased expression of vascular endothelial growth factor-C and nuclear CXCR4 in hepatocellular carcinoma is correlated with lymph node metastasis and poor outcome. Cancer Journal (Sudbury, Mass.). 15: 519-25. PMID 20010172 DOI: 10.1097/PPO.0b013e3181c6aa6b |
0.31 |
|
| 2009 |
Dai CX, Gao Q, Qiu SJ, Ju MJ, Cai MY, Xu YF, Zhou J, Zhang BH, Fan J. Hypoxia-inducible factor-1 alpha, in association with inflammation, angiogenesis and MYC, is a critical prognostic factor in patients with HCC after surgery. Bmc Cancer. 9: 418. PMID 19948069 DOI: 10.1186/1471-2407-9-418 |
0.309 |
|
| 2009 |
Dai Z, Zhou J, Qiu S, Liu Y, Fan J. Lectin-based glycoproteomics to explore and analyze hepatocellular carcinoma-related glycoprotein markers. Electrophoresis. 30: 2957-2966. PMID 19711376 DOI: 10.1002/Elps.200900064 |
0.372 |
|
| 2009 |
Yang XR, Xu Y, Yu B, Zhou J, Li JC, Qiu SJ, Shi YH, Wang XY, Dai Z, Shi GM, Wu B, Wu LM, Yang GH, Zhang BH, Qin WX, ... Fan J, et al. CD24 is a novel predictor for poor prognosis of hepatocellular carcinoma after surgery Clinical Cancer Research. 15: 5518-5527. PMID 19706825 DOI: 10.1158/1078-0432.Ccr-09-0151 |
0.345 |
|
| 2009 |
Wang H, Xiao W, Zhou Q, Chen Y, Yang S, Sheng J, Yin Y, Fan J, Zhou J. Bystin-like protein is upregulated in hepatocellular carcinoma and required for nucleologenesis in cancer cell proliferation. Cell Research. 19: 1150-64. PMID 19687802 DOI: 10.1038/Cr.2009.99 |
0.376 |
|
| 2009 |
Ding ZB, Shi YH, Zhou J, Shi GM, Ke AW, Qiu SJ, Wang XY, Dai Z, Xu Y, Fan J. Liver-intestine cadherin predicts microvascular invasion and poor prognosis of hepatitis B virus-positive hepatocellular carcinoma. Cancer. 115: 4753-65. PMID 19626651 DOI: 10.1002/cncr.24513 |
0.363 |
|
| 2009 |
Cai MY, Xu YF, Qiu SJ, Ju MJ, Gao Q, Li YW, Zhang BH, Zhou J, Fan J. Human leukocyte antigen-G protein expression is an unfavorable prognostic predictor of hepatocellular carcinoma following curative resection. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 15: 4686-93. PMID 19584149 DOI: 10.1158/1078-0432.Ccr-09-0463 |
0.364 |
|
| 2009 |
Xiang ZL, Zeng ZC, Tang ZY, Fan J, Zhuang PY, Liang Y, Tan YS, He J. Chemokine receptor CXCR4 expression in hepatocellular carcinoma patients increases the risk of bone metastases and poor survival. Bmc Cancer. 9: 176. PMID 19508713 DOI: 10.1186/1471-2407-9-176 |
0.31 |
|
| 2009 |
Dai Z, Yu L, Zhou J, Qiu S, Fan J. Molecular markers and hepatocellular carcinoma: lending a helping hand in liver transplantation? Expert Review of Gastroenterology & Hepatology. 3: 211-213. PMID 19485802 DOI: 10.1586/Egh.09.12 |
0.306 |
|
| 2009 |
Ju MJ, Qiu SJ, Gao Q, Fan J, Cai MY, Li YW, Tang ZY. Combination of peritumoral mast cells and T-regulatory cells predicts prognosis of hepatocellular carcinoma. Cancer Science. 100: 1267-74. PMID 19432885 DOI: 10.1111/j.1349-7006.2009.01182.x |
0.391 |
|
| 2009 |
Shi YH, Zhou J, Fan J. Treatment for the recurrence of hepatocellular carcinoma following liver transplantation: what is the best strategy? Cancer Biology & Therapy. 8: 22-4. PMID 19417558 DOI: 10.4161/cbt.8.7.8125 |
0.311 |
|
| 2009 |
Ju MJ, Qiu SJ, Fan J, Zhou J, Gao Q, Cai MY, Li YW, Tang ZY. Preoperative serum gamma-glutamyl transferase to alanine aminotransferase ratio is a convenient prognostic marker for Child-Pugh A hepatocellular carcinoma after operation. Journal of Gastroenterology. 44: 635-42. PMID 19387533 DOI: 10.1007/s00535-009-0050-x |
0.375 |
|
| 2009 |
He J, Zeng ZC, Tang ZY, Fan J, Zhou J, Zeng MS, Wang JH, Sun J, Chen B, Yang P, Pan BS. Clinical features and prognostic factors in patients with bone metastases from hepatocellular carcinoma receiving external beam radiotherapy. Cancer. 115: 2710-20. PMID 19382203 DOI: 10.1002/Cncr.24300 |
0.341 |
|
| 2009 |
Fan J, Yang GS, Fu ZR, Peng ZH, Xia Q, Peng CH, Qian JM, Zhou J, Xu Y, Qiu SJ, Zhong L, Zhou GW, Zhang JJ. Liver transplantation outcomes in 1,078 hepatocellular carcinoma patients: a multi-center experience in Shanghai, China. Journal of Cancer Research and Clinical Oncology. 135: 1403-12. PMID 19381688 DOI: 10.1007/S00432-009-0584-6 |
0.338 |
|
| 2009 |
Yu B, Yang X, Xu Y, Yao G, Shu H, Lin B, Hood L, Wang H, Yang S, Gu J, Fan J, Qin W. Elevated expression of DKK1 is associated with cytoplasmic/nuclear beta-catenin accumulation and poor prognosis in hepatocellular carcinomas. Journal of Hepatology. 50: 948-57. PMID 19303159 DOI: 10.1016/j.jhep.2008.11.020 |
0.384 |
|
| 2009 |
Zhou XD, Tang ZY, Ma ZC, Fan J, Wu ZQ, Qin LX, Zhou J, Yu Y, Sun HC, Qiu SJ. Twenty-year survivors after resection for hepatocellular carcinoma-analysis of 53 cases. Journal of Cancer Research and Clinical Oncology. 135: 1067-72. PMID 19294419 DOI: 10.1007/S00432-009-0546-Z |
0.394 |
|
| 2009 |
Zhou XD, Tang ZY, Fan J, Zhou J, Wu ZQ, Qin LX, Ma ZC, Sun HC, Qiu SJ, Yu Y, Ren N, Ye QH, Wang L, Ye SL. Intrahepatic cholangiocarcinoma: report of 272 patients compared with 5,829 patients with hepatocellular carcinoma. Journal of Cancer Research and Clinical Oncology. 135: 1073-80. PMID 19294418 DOI: 10.1007/S00432-009-0547-Y |
0.412 |
|
| 2009 |
Ju MJ, Qiu SJ, Fan J, Xiao YS, Gao Q, Zhou J, Li YW, Tang ZY. Peritumoral activated hepatic stellate cells predict poor clinical outcome in hepatocellular carcinoma after curative resection. American Journal of Clinical Pathology. 131: 498-510. PMID 19289585 DOI: 10.1309/AJCP86PPBNGOHNNL |
0.347 |
|
| 2009 |
Gao Q, Wang XY, Qiu SJ, Yamato I, Sho M, Nakajima Y, Zhou J, Li BZ, Shi YH, Xiao YS, Xu Y, Fan J. Overexpression of PD-L1 significantly associates with tumor aggressiveness and postoperative recurrence in human hepatocellular carcinoma. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 15: 971-9. PMID 19188168 DOI: 10.1158/1078-0432.Ccr-08-1608 |
0.313 |
|
| 2009 |
Shi YH, Ding ZB, Zhou J, Qiu SJ, Fan J. Prognostic significance of Beclin 1-dependent apoptotic activity in hepatocellular carcinoma. Autophagy. 5: 380-2. PMID 19145109 DOI: 10.4161/Auto.5.3.7658 |
0.438 |
|
| 2009 |
Ren ZG, Gan YH, Fan J, Chen Y, Wu ZQ, Qin LX, Ge NL, Zhou J, Xia JL, Wang YH, Ye QH, Wang L, Ye SL. [Treatment of postoperative recurrence of hepatocellular carcinoma with radiofrequency ablation comparing with repeated surgical resection]. Zhonghua Wai Ke Za Zhi [Chinese Journal of Surgery]. 46: 1614-6. PMID 19094752 |
0.351 |
|
| 2009 |
Fan J, Xu Y. [Strategy to improve the prognosis of liver transplantation for hepatocellular carcinoma]. Zhonghua Wai Ke Za Zhi [Chinese Journal of Surgery]. 46: 1602-5. PMID 19094749 |
0.318 |
|
| 2009 |
Bai DS, Dai Z, Zhou J, Liu YK, Qiu SJ, Tan CJ, Shi YH, Huang C, Wang Z, He YF, Fan J. Capn4 overexpression underlies tumor invasion and metastasis after liver transplantation for hepatocellular carcinoma. Hepatology (Baltimore, Md.). 49: 460-70. PMID 19053044 DOI: 10.1002/Hep.22638 |
0.435 |
|
| 2009 |
Li YW, Qiu SJ, Fan J, Gao Q, Zhou J, Xiao YS, Xu Y, Wang XY, Sun J, Huang XW. Tumor-infiltrating macrophages can predict favorable prognosis in hepatocellular carcinoma after resection. Journal of Cancer Research and Clinical Oncology. 135: 439-49. PMID 18781326 DOI: 10.1007/S00432-008-0469-0 |
0.383 |
|
| 2008 |
Zeng Z, Fan J, Tang Z, Zhou J, Wang J, Wang B, Guo W. Prognostic factors for patients with hepatocellular carcinoma with macroscopic portal vein or inferior vena cava tumor thrombi receiving external-beam radiation therapy. Cancer Science. 99: 2510-2517. PMID 19032365 DOI: 10.1111/J.1349-7006.2008.00981.X |
0.342 |
|
| 2008 |
Ding ZB, Shi YH, Zhou J, Qiu SJ, Xu Y, Dai Z, Shi GM, Wang XY, Ke AW, Wu B, Fan J. Association of autophagy defect with a malignant phenotype and poor prognosis of hepatocellular carcinoma. Cancer Research. 68: 9167-75. PMID 19010888 DOI: 10.1158/0008-5472.Can-08-1573 |
0.432 |
|
| 2008 |
Wang Z, Zhou J, Fan J, Tan CJ, Qiu SJ, Yu Y, Huang XW, Tang ZY. Sirolimus inhibits the growth and metastatic progression of hepatocellular carcinoma. Journal of Cancer Research and Clinical Oncology. 135: 715-22. PMID 19002496 DOI: 10.1007/S00432-008-0506-Z |
0.423 |
|
| 2008 |
Yang GH, Fan J, Xu Y, Qiu SJ, Yang XR, Shi GM, Wu B, Dai Z, Liu YK, Tang ZY, Zhou J. Osteopontin combined with CD44, a novel prognostic biomarker for patients with hepatocellular carcinoma undergoing curative resection. The Oncologist. 13: 1155-65. PMID 18997126 DOI: 10.1634/Theoncologist.2008-0081 |
0.315 |
|
| 2008 |
Xie LY, Fan M, Fan J, Wang J, Xu XL, Jiang GL. Metastatic hepatocellular carcinoma in the esophagus following liver transplantation. Liver Transplantation : Official Publication of the American Association For the Study of Liver Diseases and the International Liver Transplantation Society. 14: 1680-2. PMID 18975278 DOI: 10.1002/lt.21546 |
0.32 |
|
| 2008 |
Wang Z, Zhou J, Fan J, Qiu SJ, Yu Y, Huang XW, Tang ZY. Effect of rapamycin alone and in combination with sorafenib in an orthotopic model of human hepatocellular carcinoma. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 14: 5124-30. PMID 18698030 DOI: 10.1158/1078-0432.Ccr-07-4774 |
0.432 |
|
| 2008 |
Shi YH, Ding WX, Zhou J, He JY, Xu Y, Gambotto AA, Rabinowich H, Fan J, Yin XM. Expression of X-linked inhibitor-of-apoptosis protein in hepatocellular carcinoma promotes metastasis and tumor recurrence. Hepatology (Baltimore, Md.). 48: 497-507. PMID 18666224 DOI: 10.1002/Hep.22393 |
0.407 |
|
| 2008 |
Yang XR, Xu Y, Shi GM, Fan J, Zhou J, Ji Y, Sun HC, Qiu SJ, Yu B, Gao Q, He YZ, Qin WZ, Chen RX, Yang GH, Wu B, et al. Cytokeratin 10 and cytokeratin 19: predictive markers for poor prognosis in hepatocellular carcinoma patients after curative resection. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 14: 3850-9. PMID 18559605 DOI: 10.1158/1078-0432.Ccr-07-4338 |
0.435 |
|
| 2008 |
Shi GM, Xu Y, Fan J, Zhou J, Yang XR, Qiu SJ, Liao Y, Wu WZ, Ji Y, Ke AW, Ding ZB, He YZ, Wu B, Yang GH, Qin WZ, et al. Identification of side population cells in human hepatocellular carcinoma cell lines with stepwise metastatic potentials. Journal of Cancer Research and Clinical Oncology. 134: 1155-63. PMID 18470535 DOI: 10.1007/s00432-008-0407-1 |
0.345 |
|
| 2008 |
Gao Q, Wang XY, Fan J, Qiu SJ, Zhou J, Shi YH, Xiao YS, Xu Y, Huang XW, Sun J. Selection of reference genes for real-time PCR in human hepatocellular carcinoma tissues. Journal of Cancer Research and Clinical Oncology. 134: 979-86. PMID 18317805 DOI: 10.1007/s00432-008-0369-3 |
0.36 |
|
| 2008 |
Xu Y, Fan J, Zhou J, Qiu SJ, Wu ZQ, Yu Y, Hang XW, Tang ZY, Wang YQ. [Influence of tumor characteristics on the outcome of liver transplantation among patients with hepatocellular carcinoma]. Zhonghua Yi Xue Za Zhi. 87: 2101-4. PMID 17988527 |
0.37 |
|
| 2008 |
Yuan Z, Fan J, Wu ZQ, Zhou J, Qiu SJ. [Focal adhesion kinase mRNA overexpression in hepatocellular carcinoma HCC) and correlation thereof with prognosis of HCC]. Zhonghua Yi Xue Za Zhi. 87: 1256-9. PMID 17686260 |
0.403 |
|
| 2008 |
Wang Z, Fan J, Zhou J, Wu ZQ, Qiu SJ, Yu Y, Huang XW, Tang ZY. [Inhibition of growth and metastasis of hepatocellular carcinoma by rapamycin: experiment with mice]. Zhonghua Yi Xue Za Zhi. 86: 1666-70. PMID 16854316 |
0.366 |
|
| 2008 |
He YF, Fan J, Zhou J, Wu ZQ, Qiu SJ, Huang XW, Yu Y, Sun J, Xiao YS, Yang GH, Song K, Wang Z, Tang ZY, Wang YQ. [Analysis of the risk factors influencing the prognosis of orthotopic liver transplantation for hepatocellular carcinoma and summary of relevant clinical experience]. Zhonghua Yi Xue Za Zhi. 86: 1232-5. PMID 16796877 |
0.372 |
|
| 2008 |
Fan J, Zhou J, Xu Y, Qiu SJ, Wu ZQ, Yu Y, Huang XW, Tang ZY, Wang YQ. [Indication of liver transplantation for hepatocellular carcinoma: Shanghai Fudan Criteria]. Zhonghua Yi Xue Za Zhi. 86: 1227-31. PMID 16796876 |
0.366 |
|
| 2007 |
Sun HC, Zhang W, Qin LX, Zhang BH, Ye QH, Wang L, Ren N, Zhuang PY, Zhu XD, Fan J, Tang ZY. Positive serum hepatitis B e antigen is associated with higher risk of early recurrence and poorer survival in patients after curative resection of hepatitis B-related hepatocellular carcinoma. Journal of Hepatology. 47: 684-90. PMID 17854945 DOI: 10.1016/J.Jhep.2007.06.019 |
0.334 |
|
| 2007 |
Qiu JG, Fan J, Liu YK, Zhou J, Dai Z, Huang C, Tang ZY. Screening and detection of portal vein tumor thrombi-associated serum low molecular weight protein biomarkers in human hepatocellular carcinoma. Journal of Cancer Research and Clinical Oncology. 134: 299-305. PMID 17828420 DOI: 10.1007/S00432-007-0236-7 |
0.34 |
|
| 2007 |
Qiu JG, Fan J, Liu YK, Zhou J, Qiu SJ, Dai Z, Kang XN, Huang C, Yang PY, Tang ZY. [Screening low molecular weight protein biomarkers relevant to portal vein tumor thrombi in serum of patients with hepatocellular carcinoma]. Zhonghua Gan Zang Bing Za Zhi = Zhonghua Ganzangbing Zazhi = Chinese Journal of Hepatology. 15: 498-502. PMID 17669237 |
0.354 |
|
| 2007 |
Weng YQ, Qiu SJ, Liu YK, Fan J, Gao Q, Tang ZY. Down-regulation of beta-centractin might be involved in dendritic cells dysfunction and subsequent hepatocellular carcinoma immune escape: a proteomic study. Journal of Cancer Research and Clinical Oncology. 134: 179-86. PMID 17619203 DOI: 10.1007/s00432-007-0267-0 |
0.382 |
|
| 2007 |
Gao Q, Qiu SJ, Fan J, Zhou J, Wang XY, Xiao YS, Xu Y, Li YW, Tang ZY. Intratumoral balance of regulatory and cytotoxic T cells is associated with prognosis of hepatocellular carcinoma after resection. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 25: 2586-93. PMID 17577038 DOI: 10.1200/JCO.2006.09.4565 |
0.404 |
|
| 2007 |
Sun HC, Zhuang PY, Qin LX, Ye QH, Wang L, Ren N, Zhang JB, Qian YB, Lu L, Fan J, Tang ZY. Incidence and prognostic values of lymph node metastasis in operable hepatocellular carcinoma and evaluation of routine complete lymphadenectomy. Journal of Surgical Oncology. 96: 37-45. PMID 17345597 DOI: 10.1002/Jso.20772 |
0.334 |
|
| 2007 |
Wu X, Fan J, Wang X, Zhou J, Qiu S, Yu Y, Liu Y, Tang Z. Downregulation of CCR1 inhibits human hepatocellular carcinoma cell invasion. Biochemical and Biophysical Research Communications. 355: 866-71. PMID 17336272 DOI: 10.1016/J.Bbrc.2007.01.199 |
0.335 |
|
| 2007 |
Huang C, Fan J, Zhou J, Liu YK, Cui JF. [The effects of different clinicopathologic variables on serum protein fingerprint in hepatocellular carcinoma patients]. Zhonghua Wai Ke Za Zhi [Chinese Journal of Surgery]. 44: 445-9. PMID 16772076 |
0.376 |
|
| 2007 |
Wong YQ, Qiu SJ, Tang ZY, Ye SL, Liu YK, Fan J, Sun RX, Zhao Y. [Changes in the immune function of dendritic cells (DC) derived from HBV-related hepatocellular carcinoma (HCC) patient's peripheral blood monocytes (PBMC) pulsed with tumor antigen]. Zhonghua Gan Zang Bing Za Zhi = Zhonghua Ganzangbing Zazhi = Chinese Journal of Hepatology. 13: 339-42. PMID 15918966 |
0.311 |
|
| 2006 |
Zhou J, Fan J, Tang ZY, Wu ZQ, Zhou XD, Ma ZC, Tan CJ, Shi YH, Yu Y, Qiu SJ. [Time dependency of factors influencing survival of hepatocellular carcinoma patients with portal vein tumor thrombosis after surgery]. Zhonghua Yi Xue Za Zhi. 86: 3005-8. PMID 17288818 |
0.377 |
|
| 2006 |
Zhou J, Tang ZY, Wu ZQ, Zhou XD, Ma ZC, Tan CJ, Shi YH, Yu Y, Qiu SJ, Fan J. Factors influencing survival in hepatocellular carcinoma patients with macroscopic portal vein tumor thrombosis after surgery, with special reference to time dependency: a single-center experience of 381 cases. Hepato-Gastroenterology. 53: 275-80. PMID 16608039 |
0.302 |
|
| 2006 |
Sun HC, Tang ZY, Wang L, Qin LX, Ma ZC, Ye QH, Zhang BH, Qian YB, Wu ZQ, Fan J, Zhou XD, Zhou J, Qiu SJ, Shen YF. Postoperative interferon alpha treatment postponed recurrence and improved overall survival in patients after curative resection of HBV-related hepatocellular carcinoma: a randomized clinical trial. Journal of Cancer Research and Clinical Oncology. 132: 458-65. PMID 16557381 DOI: 10.1007/S00432-006-0091-Y |
0.361 |
|
| 2006 |
Cai XY, Gao Q, Qiu SJ, Ye SL, Wu ZQ, Fan J, Tang ZY. Dendritic cell infiltration and prognosis of human hepatocellular carcinoma. Journal of Cancer Research and Clinical Oncology. 132: 293-301. PMID 16421755 DOI: 10.1007/s00432-006-0075-y |
0.402 |
|
| 2006 |
Fan J, Tang ZY, Wu ZQ, Zhou J, Zhou XD, Ma ZC, Qin LX, Qiu SJ, Yu Y, Huang C. [The effects of portal vein microscopic and macroscopic tumor thrombi on post-operation patients with hepatocellular carcinoma]. Zhonghua Wai Ke Za Zhi [Chinese Journal of Surgery]. 43: 433-5. PMID 15854367 |
0.393 |
|
| 2005 |
Huang C, Fan J, Zhou J, Liu YK, Cui JF, Kang XN, Yang PY, Tang ZY. [Study of serum proteome biomarkers with relation to the formation of portal vein tumor thrombi in hepatocellular carcinoma patients]. Zhonghua Yi Xue Za Zhi. 85: 781-5. PMID 15949388 |
0.397 |
|
| 2005 |
Cai XY, Qiu SJ, Wu ZQ, Ye SL, Fan J, Zhou J, Tang ZY. [Relationship between dendritic cells and memory T lymphocytes in tumor site and prognosis of hepatocellular carcinoma]. Zhonghua Yi Xue Za Zhi. 85: 671-5. PMID 15932729 |
0.323 |
|
| 2005 |
Zeng ZC, Tang ZY, Fan J, Qin LX, Ye SL, Zhou J, Sun HC, Wang BL, Wang JH. Consideration of role of radiotherapy for lymph node metastases in patients with HCC: retrospective analysis for prognostic factors from 125 patients. International Journal of Radiation Oncology, Biology, Physics. 63: 1067-76. PMID 15913915 DOI: 10.1016/J.Ijrobp.2005.03.058 |
0.325 |
|
| 2005 |
Zhou J, Fan J, Wu ZQ, Qiu SJ, Huang XW, Yu Y, Wang Z, Sun J, Xiao YS, He YF, Yang GH, Song K, Yuan Z, Wang YQ, Tang ZY. Liver transplantation for patients with hepatocellular carcinoma at the Liver Cancer Institute of Fudan University, China. Chinese Medical Journal. 118: 654-9. PMID 15899120 |
0.388 |
|
| 2005 |
Zhou J, Xiao YS, Tang ZY, Fan J, Wu ZQ, Zhao Y, Xue Q, Shen ZZ, Liu YK, Ye SL. Transfection of thymidine phosphorylase cDNA to human hepatocellular carcinoma cells enhances sensitivity to fluoropyrimidine but augments endothelial cell migration. Journal of Cancer Research and Clinical Oncology. 131: 547-51. PMID 15864645 DOI: 10.1007/S00432-005-0669-9 |
0.347 |
|
| 2005 |
Fan J, Zhou J, Wu ZQ, Qiu SJ, Wang XY, Shi YH, Tang ZY. Efficacy of different treatment strategies for hepatocellular carcinoma with portal vein tumor thrombosis. World Journal of Gastroenterology. 11: 1215-9. PMID 15754408 DOI: 10.3748/Wjg.V11.I8.1215 |
0.399 |
|
| 2005 |
Zeng ZC, Fan J, Tang ZY, Zhou J, Qin LX, Wang JH, Sun HC, Wang BL, Zhang JY, Jiang GL, Wang YQ. A comparison of treatment combinations with and without radiotherapy for hepatocellular carcinoma with portal vein and/or inferior vena cava tumor thrombus. International Journal of Radiation Oncology, Biology, Physics. 61: 432-43. PMID 15667964 DOI: 10.1016/J.Ijrobp.2004.05.025 |
0.391 |
|
| 2005 |
Sun HC, Tang ZY, Ma ZC, Qin LX, Wang L, Ye QH, Fan J, Wu ZQ, Zhou XD. The prognostic factor for outcome following second resection for intrahepatic recurrence of hepatocellular carcinoma with a hepatitis B virus infection background. Journal of Cancer Research and Clinical Oncology. 131: 284-8. PMID 15662524 DOI: 10.1007/S00432-004-0645-9 |
0.306 |
|
| 2005 |
Tang ZY, Zhou XD, Ma ZC, Wu ZQ, Fan J, Qin LX, Yu Y. Downstaging followed by resection plays a role in improving prognosis of unresectable hepatocellular carcinoma. Hepatobiliary & Pancreatic Diseases International : Hbpd Int. 3: 495-8. PMID 15567731 |
0.41 |
|
| 2005 |
Ren ZG, Lin ZY, Xia JL, Ye SL, Ma ZC, Ye QH, Qin LX, Wu ZQ, Fan J, Tang ZY. Postoperative adjuvant arterial chemoembolization improves survival of hepatocellular carcinoma patients with risk factors for residual tumor: a retrospective control study. World Journal of Gastroenterology. 10: 2791-4. PMID 15334671 DOI: 10.3748/WJG.V10.I19.2791 |
0.378 |
|
| 2005 |
Qin LX, Ma ZC, Wu ZQ, Fan J, Zhou XD, Sun HC, Ye QH, Wang L, Tang ZY. Diagnosis and surgical treatments of hepatocellular carcinoma with tumor thrombosis in bile duct: experience of 34 patients. World Journal of Gastroenterology. 10: 1397-401. PMID 15133842 DOI: 10.3748/Wjg.V10.I10.1397 |
0.413 |
|
| 2004 |
Ren ZG, Lin ZY, Xia JL, Zhang BH, Ye SL, Chen SY, Gan YH, Wu XF, Chen Y, Ge NL, Wu ZQ, Ma ZC, Zhou XD, Fan J, Qin LX, et al. [Effect of postoperative transcatheter arterial chemoembolization on hepatocellular carcinoma patients with residual tumor]. Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]. 26: 116-8. PMID 15059334 |
0.387 |
|
| 2003 |
Fan J, Wu ZQ, Zhou J, Qiu SJ, Chen RX, Shi YH, Tang ZY. [Comparison of the results and therapies for hepatocellular carcinoma with tumor thrombosis in portal vein]. Zhonghua Wai Ke Za Zhi [Chinese Journal of Surgery]. 41: 801-4. PMID 14703450 |
0.402 |
|
| 2003 |
Tang ZY, Ye SL, Liu YK, Qin LX, Sun HC, Ye QH, Wang L, Zhou J, Qiu SJ, Li Y, Ji XN, Liu H, Xia JL, Wu ZQ, Fan J, et al. A decade's studies on metastasis of hepatocellular carcinoma. Journal of Cancer Research and Clinical Oncology. 130: 187-96. PMID 14685850 DOI: 10.1007/S00432-003-0511-1 |
0.445 |
|
| 2003 |
Zhou J, Tang ZY, Fan J, Wu ZQ, Ji Y, Xiao YS, Shi YH, Li XM, Sun QM, Liu YK, Ye SL. Capecitabine inhibits postoperative recurrence and metastasis after liver cancer resection in nude mice with relation to the expression of platelet-derived endothelial cell growth factor. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 9: 6030-7. PMID 14676129 |
0.345 |
|
| 2003 |
Fan J, Wu ZQ, Zhou J, Qiu SJ, Shi YH, Chen RX, Tang ZY. Hepatocellular carcinoma associated with tumor thrombosis in the portal vein: the effects of different treatments. Hepatobiliary & Pancreatic Diseases International : Hbpd Int. 2: 513-9. PMID 14627511 |
0.408 |
|
| 2002 |
Yan FH, Zhou KR, Cheng JM, Wang JH, Yan ZP, Da RR, Fan J, Ji Y. Role and limitation of FMPSPGR dynamic contrast scanning in the follow-up of patients with hepatocellular carcinoma treated by TACE. World Journal of Gastroenterology. 8: 658-62. PMID 12174374 DOI: 10.3748/wjg.v8.i4.658 |
0.354 |
|
| 2002 |
Wu X, Lin Z, Fan J, Lu J, Wang L, Tang Z. [Quantitation of alpha-fetoprotein messenger RNA in peripheral blood of nude mice and its relationship with tumor recurrence and metastasis after curative resection of hepatocellular carcinoma]. Zhonghua Gan Zang Bing Za Zhi = Zhonghua Ganzangbing Zazhi = Chinese Journal of Hepatology. 10: 189-91. PMID 12113675 |
0.326 |
|
| 2001 |
Zhou J, Tang ZY, Fan J, Wu ZQ, Ji Y, Ye SL. The potential of plasma thrombomodulin as a biomarker of portal vein tumor thrombus in hepatocellular carcinoma. Journal of Cancer Research and Clinical Oncology. 127: 559-64. PMID 11570577 DOI: 10.1007/S004320100237 |
0.39 |
|
| 1998 |
Tang ZY, Zhou XD, Ma ZC, Wu ZQ, Fan J, Lin ZY, Lu JZ, Liu KD, Ye SL, Yang BH. Multimodality treatment of hepatocellular carcinoma. Journal of Gastroenterology and Hepatology. 13: S315-S319. PMID 28976647 DOI: 10.1111/j.1440-1746.1998.tb01901.x |
0.364 |
|
| Show low-probability matches. |